Transplant · Exercise · NutritionTransplant · Ehersisyo · NutrisyonTransplant · Ehersisyo · NutrisyonTransplant · Ehersisyu · Nutrisyun

Getting Fit for a Kidney TransplantPagpapalakas para sa Kidney TransplantPagpalig-on alang sa Kidney TransplantPamagpasikan para king Kidney Transplant

Build strength while you wait, recover better after: exercise, protein, and support, and what the first trials really showed.Magpalakas habang naghihintay, mas gumaling pagkatapos: ehersisyo, protina, at suporta, at ang tunay na ipinakita ng mga unang trial.Pagpalig-on samtang naghulat, mas maayo nga pagkaayo human: ehersisyo, protina, ug suporta, ug ang tinuod nga gipakita sa unang mga trial.Magpasikan kabang manaya, mas mayap a pamagmayap kaibat: ehersisyu, protina, ampo suporta, at ing tutung pepakit dareng mumunang trial.

PublishedNailathalaGipatikPepalwal: ReferencesMga SanggunianMga TinubdanReng Reperensya: 29 Read timeOras ng pagbasaOras sa pagbasaOras ning pamamasa:
⚠️

Before you start, and when to stopBago magsimula, at kailan titigilSa dili pa magsugod, ug kanus-a mohunongBayu ka mamimpisan, at kapilan tumigil

Ask your nephrologist or transplant team before starting, especially if you have chest pain, known heart disease, a recent hospital stay, very high potassium, or a fistula or graft arm (no heavy weights on that arm). Stop exercising and get care right away for chest pain or pressure, fainting, severe breathlessness, or a racing or irregular heartbeat.Magtanong sa iyong nephrologist o transplant team bago magsimula, lalo na kung may pananakit ng dibdib, kilalang sakit sa puso, kamakailang pagka-ospital, napakataas na potassium, o brasong may fistula o graft (walang mabigat na pabigat sa brasong iyon). Tumigil sa pag-eehersisyo at magpatingin agad kapag may pananakit o paninikip ng dibdib, pagkahimatay, matinding hirap sa paghinga, o mabilis o iregular na tibok ng puso.Pangutana sa imong nephrologist o transplant team sa dili pa magsugod, ilabina kung adunay sakit sa dughan, nahibal-an nga sakit sa kasingkasing, bag-o lang na-ospital, taas kaayo nga potassium, o bukton nga adunay fistula o graft (walay bug-at nga pabug-at sa maong bukton). Hunong sa pag-ehersisyo ug pagpatambal dayon kung adunay sakit o pagpiit sa dughan, pagkaluya, grabe nga kalisod sa pagginhawa, o paspas o dili regular nga pitik sa kasingkasing.Ikutang mu king nephrologist o transplant team bayu ka mamimpisan, lalu na nung atin kang sakit king salu, kilalang sakit king pusu, bayu kang menaliwa ospital, mataas a mataas a potassium, o gamat a maki fistula o graft (alang mabayat a pabigat king gamat a ita). Tumigil ka mag-ehersisyu at magpakonsulta pasibayu nung atin sakit o pamipitpit king salu, pamanyampu, masikan a kairapan king pamangisnawa, o masalusu o e regular a pamitibuk ning pusu.

💡

The one-minute answerAng sagot sa isang minutoAng tubag sa usa ka minutoIng sagot king metung a minutu

  1. Many people waiting for a transplant become weaker on dialysis. Getting stronger before surgery (prehabilitation) is safe for most people and helps you feel and move better.Maraming naghihintay ng transplant ang humihina habang naka-dialysis. Ang pagpapalakas bago ang operasyon (prehabilitation) ay ligtas para sa karamihan at nakakatulong para gumaan ang pakiramdam at galaw.Daghang naghulat og transplant ang mohuyang samtang naka-dialysis. Ang pagpalig-on sa dili pa ang operasyon (prehabilitation) luwas sa kadaghanan ug makatabang nga mas maayo ang pamati ug paglihok.Dakal kareng manaya transplant ing malunus kabang naka-dialysis. Ing pamagpasikan bayu ning operasyun (prehabilitation) ligtas ya para king kadakalan at makatulung bang mayap ing pamakiramdam at galo.
  2. A good plan combines exercise (walking or cycling plus light strength work), enough protein and calories, and support for stress and mood.Ang magandang plano ay pinagsasama ang ehersisyo (paglalakad o pagbibisikleta at magaang na strength exercise), sapat na protina at calories, at suporta sa stress at damdamin.Ang maayong plano naghiusa sa ehersisyo (paglakaw o pagbisikleta ug gaan nga strength exercise), igo nga protina ug calories, ug suporta sa stress ug pagbati.Ing mayap a plano pisasamu na ing ehersisyu (paglakad o pamagbisikleta ampo magaan a strength exercise), sapat a protina ampo calories, ampo suporta king stress at pamakiramdam.
  3. Early trials show better fitness and strength, but the benefit fades if you stop. Make it a routine, not a short program. No trial yet proves it makes the transplant itself go better.Ipinapakita ng mga unang trial ang mas magandang fitness at lakas, pero nawawala ito kapag tumigil. Gawin itong nakagawian, hindi maikling programa. Wala pang trial na nagpapatunay na pinagaganda nito ang mismong transplant.Gipakita sa unang mga trial ang mas maayong fitness ug kusog, apan mawala kini kung mohunong. Himoa kining naandan, dili mubo nga programa. Wala pay trial nga nagpamatuod nga mopaayo kini sa transplant mismo.Pakit da reng mumunang trial ing mas mayap a fitness ampo sikan, pero mawala ya nung tumigil. Gawan me yang anggaga, ali malagad a programa. Ala pang trial a papatune nung payapan na ing transplant mismu.
  4. After transplant, most people shift to a heart-healthy diet with more vegetables, fruit, and fiber, and must avoid pomelo (suha) and grapefruit with tacrolimus. Ask your team what is right for you.Pagkatapos ng transplant, karamihan ay lumilipat sa pagkaing mabuti sa puso na mas maraming gulay, prutas, at fiber, at dapat iwasan ang suha (pomelo) at grapefruit kapag umiinom ng tacrolimus. Itanong sa team kung ano ang tama para sa iyo.Human sa transplant, kadaghanan mobalhin sa pagkaon nga maayo sa kasingkasing nga mas daghang utanon, prutas, ug fiber, ug kinahanglan likayan ang suha (pomelo) ug grapefruit kung nag-inom og tacrolimus. Pangutana sa team kung unsa ang husto alang kanimo.Kaibat ning transplant, kadakalan lilipat la king pamangan a mayap king pusu a mas dakal a gule, bunga, ampo fiber, at dapat iwasan ing suha (pomelo) ampo grapefruit nung minum tacrolimus. Ikutang mu king team nung nanu ing tama para keka.
💡

For clinicians: the 60-second version

Physical frailty (Fried ≥3) affects about 1 in 6 kidney transplant (KT) candidates in US registry estimates, and 40% of FRAILMar participants met a looser ≥2 threshold. It is independently associated with lower likelihood of listing, waitlist mortality, and post-transplant death. One randomized controlled trial (RCT), FRAILMar (n=121), shows that 8 weeks of supervised multicomponent exercise with post-session protein improves exercise capacity, grip, and muscle size, including in frail patients, but effects wane by 6 months and no trial yet shows better transplant outcomes. Prescribe it as a maintained, dialysis-embedded program; screen only if you have a pathway to act (the GOAL lesson); and plan the post-transplant shift to a Mediterranean-style diet with tacrolimus food-interaction counseling.

Paalala: draft pa ang salin na ito at hinihintay ang pagsusuri ng katutubong tagapagsalita. Ang Ingles na bersyon ang sinuri.Pahinumdom: draft pa kini nga hubad ug naghulat sa pagsusi sa lumad nga mamumulong. Ang Ingles nga bersyon ang nasusi.Paalala: draft pa ing salin a iti at manaya king pamanigaral ning katutubung manyalita. Ing Ingles a bersyun ing linawe.

Why your strength matters while you waitBakit mahalaga ang iyong lakas habang naghihintayNganong importante ang imong kusog samtang naghulatNung bakit mayalaga ing sikan mu kabang manaya ka

Think of a kidney transplant as a long climb. The surgery, the anesthesia, the first days in bed, and the new medicines all draw on your body's reserve: the extra strength, muscle, and stamina you keep in the bank. People who arrive with more in the bank usually get up, walk, and go home sooner. Prehabilitation means building that reserve before surgery instead of only rebuilding it after.Isipin ang kidney transplant bilang isang mahabang pag-akyat. Ang operasyon, ang anesthesia, ang mga unang araw sa kama, at ang mga bagong gamot ay kumukuha lahat sa reserba ng iyong katawan: ang dagdag na lakas, kalamnan, at tibay na nakaipon. Ang mga taong may mas malaking ipon ay kadalasang mas maagang nakakabangon, nakakalakad, at nakakauwi. Ang prehabilitation ay ang pagpapalakas ng reserbang iyon bago ang operasyon, hindi lamang pagkatapos.Hunahunaa ang kidney transplant isip usa ka taas nga pagsaka. Ang operasyon, ang anesthesia, ang unang mga adlaw sa higdaanan, ug ang bag-ong mga tambal tanan mokuha gikan sa reserba sa imong lawas: ang dugang kusog, kaunoran, ug kalig-on nga natigom. Ang mga tawo nga mas daghan og natigom kasagaran mas dali nga makabangon, makalakaw, ug makauli. Ang prehabilitation mao ang pagpalig-on sa maong reserba sa dili pa ang operasyon, dili lang human niini.Isipan mu ing kidney transplant antimong mabayang pamanik. Ing operasyun, ing anesthesia, deng mumunang aldo king kama, ampo reng bayung gamot, kukwa la ngan king reserba ning katawan mu: ing dagdag a sikan, laman, at tibe a atipun mu. Deng taung maki mas maragul a atipun, kalupan mas masikan dang makabangun, makalakad, at makabalik bale. Ing prehabilitation ya ing pamagpasikan king reserbang ita bayu ing operasyun, ali mu pamu kaibat.

Two people facing the climb of recovery: one with a near-empty reserve gauge, one with a full gauge.

Surgery draws on your reserve. Prehabilitation fills the tank before the climb.Kumukuha ang operasyon sa iyong reserba. Pinupuno ng prehabilitation ang tangke bago ang pag-akyat.Mokuha ang operasyon sa imong reserba. Pun-on sa prehabilitation ang tangke sa dili pa ang pagsaka.Kukwa ya ing operasyun king reserba mu. Pupunan ning prehabilitation ing tangke bayu ning pamanik.

What dialysis does to muscleAno ang ginagawa ng dialysis sa kalamnanUnsa ang buhaton sa dialysis sa kaunoranNanu ing gagawan ning dialysis king laman

Muscle is not fixed tissue. Every day your body breaks some muscle protein down and builds some back up. In kidney failure the balance tips toward breakdown: waste products and acid build up, low-grade inflammation stays switched on, insulin works less well, appetite falls, and some protein and amino acids are lost into the dialysis fluid. Add long hours sitting during and after treatment, and the legs weaken first. Weak legs mean slower walking, more tiredness, and more falls, which in turn means even less activity. That downward loop is what doctors call frailty.Hindi permanenteng tissue ang kalamnan. Araw-araw, may sinisira at may binubuong muli ang katawan na protina ng kalamnan. Sa kidney failure, mas lumalamang ang pagkasira: naiipon ang dumi at asido, tuloy-tuloy ang mahinang pamamaga, humihina ang bisa ng insulin, bumababa ang gana sa pagkain, at may protina at amino acid na nawawala sa dialysis fluid. Idagdag pa ang mahabang oras ng pagkakaupo habang at pagkatapos ng gamutan, kaya unang humihina ang mga binti. Ang mahinang binti ay nangangahulugang mas mabagal na paglakad, mas madaling mapagod, at mas madalas na pagkadapa, na lalong nagpapababa ng galaw. Ang pababang ikot na ito ang tinatawag ng doktor na frailty.Dili permanente nga tisyu ang kaunoran. Matag adlaw, ang lawas mobungkag og pipila ka protina sa kaunoran ug motukod usab. Sa kidney failure, mas modaog ang pagkabungkag: matigom ang hugaw ug asido, padayon ang hinay nga panghubag, mohinay ang epekto sa insulin, mous-os ang gana sa pagkaon, ug adunay protina ug amino acid nga mawala sa dialysis fluid. Idugang pa ang taas nga oras nga naglingkod samtang ug human sa pagtambal, mao nga ang mga bitiis ang unang mohuyang. Ang huyang nga bitiis nagpasabot og mas hinay nga paglakaw, mas dali nga kakapoy, ug mas kanunay nga pagkapukan, nga mas mopaubos pa sa kalihokan. Kini nga paubos nga liko ang gitawag sa doktor nga frailty.E permanenteng tissue ing laman. Aldo-aldo, kakalungkagan ning katawan ing protina ning laman at bubuan ne pasibayu. King kidney failure, mas malagu ing pamakalungkag: mitipun la reng dumi ampo asidu, tuloy-tuloy ing mapaling pamagbaga, maluyang ing insulin, manaba ing gana mangan, at atin protina ampo amino acid a mawala king dialysis fluid. Idagdag pa ing mabayang oras a makalukluk kabang at kaibat ning pamanulu, anya mumuna lang malunus deng bitis. Ing malunus a bitis buri nang sabyan mas malambang paglakad, mas maragul a kapagalan, at mas maralas a pamanabu, a lalung pamababa king galo. Ing pababang ikut a iti ing awagan da reng doktor a frailty.

Balance scale: acid, inflammation, protein loss in dialysis fluid, sitting, and poor appetite outweigh exercise, protein, energy, and sleep.

Kidney failure tips muscle toward breakdown. Exercise, protein, energy, and sleep push the balance back.Itinutulak ng kidney failure ang kalamnan patungo sa pagkasira. Ibinabalik ng ehersisyo, protina, enerhiya, at tulog ang timbang.Iduso sa kidney failure ang kaunoran padulong sa pagkabungkag. Ibalik sa ehersisyo, protina, enerhiya, ug tulog ang timbang.Itulak ning kidney failure ing laman papunta king pamakalungkag. Ibalik da ning ehersisyu, protina, enerhiya, ampo tudtud ing timbang.

The five signs of frailty, in plain wordsAng limang palatandaan ng frailty, sa simpleng salitaAng lima ka timailhan sa frailty, sa yanong pulongDeng limang tanda ning frailty, king simpleng amanu

The most widely used definition, the Fried frailty phenotype, counts five things. Having one or two makes you prefrail; three or more makes you frail. Many transplant programs score the first two of these directly.Ang pinakaginagamit na depinisyon, ang Fried frailty phenotype, ay nagbibilang ng limang bagay. Kapag may isa o dalawa, prefrail ka; kapag tatlo o higit pa, frail ka. Maraming transplant program ang direktang sumusukat sa unang dalawa.Ang labing gigamit nga depinisyon, ang Fried frailty phenotype, nag-ihap og lima ka butang. Kung naa kay usa o duha, prefrail ka; kung tulo o labaw pa, frail ka. Daghang transplant program ang direktang mosukod sa unang duha.Ing pekamaralas a gamitan a depinisyun, ing Fried frailty phenotype, bibilang yang limang bage. Nung atin kang metung o adwa, prefrail ka; nung atlu o mas dakal, frail ka. Dakal a transplant program ing direktang sukatan ing mumunang adwa.

Five frailty signs: weak grip, slow walking, always tired, little activity, weight loss without trying; 0 signs robust, 1–2 prefrail, 3 or more frail.

Count the signs: none means robust, one or two means prefrail, three or more means frail. Both prefrail and frail can improve.Bilangin ang palatandaan: wala ay robust, isa o dalawa ay prefrail, tatlo o higit pa ay frail. Parehong maaaring gumaling ang prefrail at frail.Ihapa ang timailhan: wala kay robust, usa o duha kay prefrail, tulo o labaw pa kay frail. Pareho nga mahimong mouswag ang prefrail ug frail.Bilangan me ing tanda: ala yang robust, metung o adwa yang prefrail, atlu o mas dakal yang frail. Pareu dang malyaring miyayap ing prefrail ampo frail.

Frailty is common on the waiting list. In US registry estimates, about 1 in 6 transplant candidates is fully frail (three or more signs). In the largest prehabilitation trial so far, about 4 in 10 waitlisted people had at least two. In a 2025 study of 2,708 transplant candidates in the United States, 4 in 10 had low physical activity and those with low physical function were about half as likely to be placed on the list and more likely to die while waiting.Karaniwan ang frailty sa waiting list. Sa tantiya ng registry sa Estados Unidos, mga 1 sa bawat 6 na transplant candidate ang ganap na frail (tatlo o higit pang palatandaan). Sa pinakamalaking pag-aaral sa prehabilitation sa ngayon, mga 4 sa bawat 10 taong nasa waiting list ang may hindi bababa sa dalawa. Sa isang pag-aaral noong 2025 sa 2,708 transplant candidate sa Estados Unidos, 4 sa bawat 10 ang may mababang galaw, at ang may mahinang pisikal na kakayahan ay halos kalahati lamang ang tsansang mailagay sa listahan at mas malamang na mamatay habang naghihintay.Kasagaran ang frailty sa waiting list. Sa banabana sa registry sa Estados Unidos, mga 1 sa matag 6 ka transplant candidate ang hingpit nga frail (tulo o labaw pa nga timailhan). Sa labing dako nga pagtuon sa prehabilitation karon, mga 4 sa matag 10 ka tawo nga anaa sa waiting list ang adunay labing menos duha. Sa usa ka pagtuon niadtong 2025 sa 2,708 ka transplant candidate sa Estados Unidos, 4 sa matag 10 ang ubos og kalihokan, ug ang mga huyang og pisikal nga abilidad hapit katunga lang ang tsansa nga mabutang sa lista ug mas lagmit nga mamatay samtang naghulat.Karaniwan ya ing frailty king waiting list. King tantya ning registry king Estados Unidos, manga 1 king balang 6 a transplant candidate ing ganap a frail (atlu o mas dakal a tanda). King pekamaragul a pamag-aral king prehabilitation ngeni, manga 4 king balang 10 a tau king waiting list ing atin anggang adwa. King metung a pamag-aral kaniting 2025 king 2,708 a transplant candidate king Estados Unidos, 4 king balang 10 ing mababa ing galo, at deng malunus ing pisikal a kayabe, kalahati mu ing tsansang maiyabe king listahan at mas malyaring mate kabang manaya.

Frailty also follows people into surgery. In one well-known study of 537 transplant recipients, 5-year survival was 91.5% in those who were not frail and 77.5% in those who were frail. This kind of study shows an association: frail people are often sicker in other ways too. It does not prove that getting stronger will close that gap, which is exactly what the newer trials are trying to answer.Sumasama rin ang frailty hanggang sa operasyon. Sa isang kilalang pag-aaral ng 537 transplant recipient, ang 5-taong survival ay 91.5% sa mga hindi frail at 77.5% sa mga frail. Ang ganitong pag-aaral ay nagpapakita ng kaugnayan: ang mga frail ay madalas na mas maysakit din sa ibang paraan. Hindi nito napapatunayan na ang paglakas ay magsasara sa agwat na iyon, at iyon mismo ang sinusubukang sagutin ng mga bagong trial.Mosunod usab ang frailty hangtod sa operasyon. Sa usa ka ilado nga pagtuon sa 537 ka transplant recipient, ang 5-ka-tuig nga survival 91.5% sa dili frail ug 77.5% sa frail. Kini nga matang sa pagtuon nagpakita og kalambigitan: ang mga frail kasagaran mas masakiton usab sa ubang paagi. Wala kini nagpamatuod nga ang paglig-on mosira sa maong gintang, ug mao gyud kana ang gusto tubagon sa mga bag-ong trial.Tutuki ya mu naman ing frailty anggang king operasyun. King metung a kilalang pamag-aral king 537 a transplant recipient, ing 5-banwang survival 91.5% kareng ali frail at 77.5% kareng frail. Ing makanyan a pamag-aral pakit ne ing kaugnayan: deng frail kalupan mas masakit la naman king aliwang paralan. E na papatune nung ing pamagsikan isara na ing agwat a ita, at ita mismu ing buri dang sagutan dareng bayung trial.

Illustrative chart: fitness declines on usual care while waiting, rises during a prehabilitation program, and falls back if exercise stops.

An illustration, not study data: without action, fitness tends to drift down on the waiting list. A program lifts it, but the gain fades if the habit stops.Isang larawan, hindi datos ng pag-aaral: kung walang gagawin, kadalasang bumababa ang fitness habang nasa waiting list. Itinataas ito ng isang programa, pero nawawala ang pakinabang kapag tumigil ang ugali.Usa ka hulagway, dili datos sa pagtuon: kung walay buhaton, kasagaran mous-os ang fitness samtang anaa sa waiting list. Gipataas kini sa usa ka programa, apan mawala ang kaayohan kung mohunong ang batasan.Metung a larawan, ali datos ning pamag-aral: nung alang gagawan, kalupan manaba ing fitness kabang atiu king waiting list. Pataasan ne ning metung a programa, pero mawala ing kapakanan nung tumigil ing ugali.

What prehabilitation is: three pillarsAno ang prehabilitation: tatlong haligiUnsa ang prehabilitation: tulo ka haligiNanu ing prehabilitation: atlung adigi

Prehabilitation is not one exercise class. It is a plan with three parts that work together, because muscle needs all three to grow: a reason to grow (exercise), the building blocks (protein and enough calories), and the energy and motivation to keep going (mind and mood).Ang prehabilitation ay hindi iisang klase ng ehersisyo. Ito ay plano na may tatlong bahaging nagtutulungan, dahil kailangan ng kalamnan ang tatlo para lumaki: dahilan para lumaki (ehersisyo), mga materyales sa pagbuo (protina at sapat na calories), at lakas ng loob para magpatuloy (isip at damdamin).Ang prehabilitation dili usa lang ka klase sa ehersisyo. Kini usa ka plano nga adunay tulo ka bahin nga nagtinabangay, tungod kay kinahanglan sa kaunoran ang tulo aron motubo: rason aron motubo (ehersisyo), mga materyales sa pagtukod (protina ug igo nga calories), ug kusog sa kabubut-on aron magpadayon (hunahuna ug pagbati).Ing prehabilitation e metung mung klasi ning ehersisyu. Plano ya a atin atlung bage a magtulungan, uli ta kailangan ning laman ing atlu bang lumagu: dahilan bang lumagu (ehersisyu), materyales king pamanyari (protina at sapat a calories), ampo sikan ning lub bang tuloy-tuloy (isip at pamakiramdam).

Three-pillar infographic: exercise, nutrition, and mind, each with simple weekly targets for people waiting for a kidney transplant.

The three pillars of prehabilitation: move most days, eat enough protein and energy, and look after stress, sleep, and mood.Ang tatlong haligi ng prehabilitation: gumalaw sa karamihan ng araw, kumain ng sapat na protina at enerhiya, at alagaan ang stress, tulog, at damdamin.Ang tulo ka haligi sa prehabilitation: paglihok sa kadaghanan sa mga adlaw, pagkaon og igo nga protina ug enerhiya, ug pag-atiman sa stress, tulog, ug pagbati.Deng atlung adigi ning prehabilitation: gumalo king kadakalan a aldo, mangan sapat a protina ampo enerhiya, at ingatan ing stress, tudtud, ampo pamakiramdam.

What the first trial foundAno ang natuklasan ng unang trialUnsa ang nakit-an sa unang trialNanu ing akit ning mumunang trial

The first randomized trial in people waiting for a kidney transplant, called FRAILMar, was done in Barcelona, Spain, and published in 2025. It enrolled 121 people (average age 63). Half were assigned by chance to a supervised program: one-hour sessions three times a week for 8 weeks, mixing walking or cycling, light weights, and breathing-muscle training, with a protein drink after each session. The other half had usual care.Ang unang randomized trial sa mga taong naghihintay ng kidney transplant, na tinatawag na FRAILMar, ay ginawa sa Barcelona, Spain, at nailathala noong 2025. Kasama rito ang 121 katao (average na edad 63). Ang kalahati ay napili nang random para sa isang supervised na programa: isang oras na sesyon, tatlong beses kada linggo sa loob ng 8 linggo, na may paglalakad o pagbibisikleta, magaang na pabigat, at pagsasanay ng kalamnan sa paghinga, na may protein drink pagkatapos ng bawat sesyon. Ang kalahati naman ay may karaniwang pangangalaga.Ang unang randomized trial sa mga tawo nga naghulat og kidney transplant, gitawag og FRAILMar, gihimo sa Barcelona, Spain, ug gipatik niadtong 2025. Naglakip kini og 121 ka tawo (kasagarang edad 63). Ang katunga gipili nga random alang sa usa ka supervised nga programa: usa ka oras nga sesyon, tulo ka higayon matag semana sulod sa 8 ka semana, nga adunay paglakaw o pagbisikleta, gaan nga pabug-at, ug pagbansay sa kaunoran sa pagginhawa, uban ang protein drink human sa matag sesyon. Ang laing katunga adunay kasagarang pag-atiman.Ing mumunang randomized trial kareng taung manaya king kidney transplant, a awagan dang FRAILMar, megawa king Barcelona, Spain, at mibalita kaniting 2025. Kayabe na ing 121 a tau (karaniwang edad 63). Ing kalahati mipili lang random para king metung a supervised a programa: metung a oras a sesyun, makatlu kada dominggu king lalam ning 8 dominggu, a maki paglakad o pamagbisikleta, magaan a pabigat, ampo pamagsanay ning laman king pamangisnawa, a maki protein drink kaibat ning balang sesyun. Ing kalahati maki karaniwang pamanalaga.

After 8 weeks, the exercise group had better exercise capacity, a stronger grip, stronger breathing muscles, and thicker thigh muscle on ultrasound than the usual-care group, and frail participants gained too. It did not change peak oxygen use, 6-minute walking distance, or overall frailty status. Two honest cautions came with it. About one in three eligible people chose not to join. And by 6 months, even with monthly phone check-ins, activity, muscle thickness, and frailty scores had slipped back toward where they started.Pagkalipas ng 8 linggo, mas maganda ang kakayahang mag-ehersisyo, mas malakas ang hawak, mas malakas ang kalamnan sa paghinga, at mas makapal ang kalamnan sa hita sa ultrasound ng grupong nag-ehersisyo kaysa sa grupong may karaniwang pangangalaga, at lumakas din ang mga frail. Hindi nito binago ang pinakamataas na paggamit ng oxygen, ang layo ng 6 na minutong lakad, o ang kabuuang frailty status. Dalawang tapat na babala ang kasama nito. Mga isa sa bawat tatlong kwalipikado ang piniling hindi sumali. At pagdating ng 6 na buwan, kahit may buwanang tawag sa telepono, bumalik malapit sa simula ang galaw, kapal ng kalamnan, at frailty score.Human sa 8 ka semana, mas maayo ang abilidad sa pag-ehersisyo, mas kusgan ang kupot, mas kusgan ang kaunoran sa pagginhawa, ug mas baga ang kaunoran sa paa sa ultrasound sa grupo nga nag-ehersisyo kaysa sa grupo nga adunay kasagarang pag-atiman, ug mikusog usab ang mga frail. Wala kini nag-usab sa kinatas-ang paggamit sa oxygen, sa gilay-on sa 6 ka minutong lakaw, o sa kinatibuk-ang frailty status. Duha ka matinud-anon nga pahimangno ang kauban niini. Mga usa sa matag tulo nga kwalipikado ang mipili nga dili moapil. Ug pag-abot sa 6 ka bulan, bisan adunay binulan nga tawag sa telepono, mibalik duol sa sinugdanan ang kalihokan, gibag-on sa kaunoran, ug frailty score.Kaibat ning 8 dominggu, mas mayap ing kayabe mag-ehersisyu, mas masikan ing kapit, mas masikan ing laman king pamangisnawa, at mas makapal ing laman king pupu king ultrasound ning grupung mig-ehersisyu kesa king grupung maki karaniwang pamanalaga, at sinikan la naman deng frail. E na beguan ing pekamatas a pamanggamit oxygen, ing layu ning 6 minutung lakad, o ing kabuuang frailty status. Adwang tapat a paalala ing kayabe na. Manga metung king balang atlung kwalipikadu ing pinili dang e makiyabe. At pamanyabi ning 6 bulan, maski atin buwanang tawag king telepunu, bumalik ya malapit king pamimpisan ing galo, kapal ning laman, ampo frailty score.

🔬

What the trials have not shown yetAng hindi pa naipapakita ng mga trialAng wala pa mapakita sa mga trialIng e pa pepakit dareng trial

So far, no randomized trial has even tested whether prehabilitation leads to a longer-lasting kidney, fewer complications, or a shorter hospital stay after transplant. The trials measured fitness and muscle, which are steps on the way, not the final goal. We recommend it because it is safe for most people, it helps you feel and move better now, and it keeps you ready, not because it guarantees a better transplant.Sa ngayon, wala pang randomized trial na sumubok man lang kung ang prehabilitation ay nagdudulot ng mas matagal na bato, mas kaunting komplikasyon, o mas maikling pananatili sa ospital pagkatapos ng transplant. Ang sinukat ng mga trial ay fitness at kalamnan, na mga hakbang patungo roon, hindi ang huling layunin. Inirerekomenda namin ito dahil ligtas ito para sa karamihan, nakakatulong ito para mas gumaan ang pakiramdam at galaw mo ngayon, at pinapanatili kang handa, hindi dahil garantisado nitong mas magiging maganda ang transplant.Sa pagkakaron, wala pay randomized trial nga misulay bisan kung ang prehabilitation mohatag og mas dugay nga bato, mas gamay nga komplikasyon, o mas mubo nga pagpabilin sa ospital human sa transplant. Ang gisukod sa mga trial mao ang fitness ug kaunoran, nga mga lakang padulong didto, dili ang katapusang tumong. Girekomenda namo kini tungod kay luwas kini sa kadaghanan, makatabang kini nga mas maayo ang imong pamati ug paglihok karon, ug magpabilin kang andam, dili tungod kay gigarantiya niini ang mas maayong transplant.Ngeni, ala pang randomized trial a sinubuk man mu nung ing prehabilitation magdala yang mas maboyung batu, mas dikit a komplikasyun, o mas malagad a pamanatili king ospital kaibat ning transplant. Ing sinukat dareng trial ing fitness ampo laman, a manga makbang papunta karin, ali ing tauling layunin. Irekomenda me uli ta ligtas ya para king kadakalan, makatulung ya bang mas mayap ing pamakiramdam at galo mu ngeni, at panatili na kang handa, ali uli ta garantisadu nang mas mayap ing transplant.

Evidence tiers: strength, grip, muscle thickness, and breathing muscles improved; aerobic capacity, walk distance, and frailty status did not change; transplant outcomes not yet tested.

What we know so far: strength improves, some measures did not change, and effects on the transplant itself are not yet tested.Ang alam natin sa ngayon: lumalakas ang katawan, may mga sukat na hindi nagbago, at hindi pa nasusubok ang epekto sa mismong transplant.Ang atong nahibaloan karon: mokusog ang lawas, adunay mga sukod nga wala mausab, ug wala pa masulayi ang epekto sa transplant mismo.Ing balu tamu ngeni: sumikan ing katawan, atin sukat a e mibago, at e pa asubuk ing epektu king transplant mismu.

A starter weekly plan you can do at homeIsang panimulang lingguhang plano na kaya sa bahayUsa ka sinugdanang semanal nga plano nga mahimo sa balayMetung a panimulang lingguhang plano a kaya king bale

Muscle grows when it is asked to do a little more than it is used to, then given food and rest to repair. That is why the plan mixes two kinds of work. Aerobic exercise (walking, cycling) trains the heart, lungs, and the tiny energy factories inside muscle cells. Resistance exercise (chair stands, light weights) sends the strongest signal for muscle to build protein. Breathing exercises train the diaphragm, which helps you cough and breathe deeply after surgery.Lumalaki ang kalamnan kapag pinagagawa ito nang kaunti pa sa nakasanayan, at saka binibigyan ng pagkain at pahinga para magpagaling. Kaya pinaghahalo ng plano ang dalawang uri ng gawain. Ang aerobic na ehersisyo (paglalakad, pagbibisikleta) ay nagsasanay sa puso, baga, at sa maliliit na pabrika ng enerhiya sa loob ng mga selula ng kalamnan. Ang resistance na ehersisyo (pagtayo mula sa upuan, magaang na pabigat) ang nagbibigay ng pinakamalakas na senyales para bumuo ng protina ang kalamnan. Ang breathing exercise ay nagsasanay sa diaphragm, na tumutulong sa pag-ubo at malalim na paghinga pagkatapos ng operasyon.Motubo ang kaunoran kung pabuhaton kini og gamay nga labaw sa naandan, unya hatagan og pagkaon ug pahulay aron mamaayo. Mao nga gisagol sa plano ang duha ka matang sa buluhaton. Ang aerobic nga ehersisyo (paglakaw, pagbisikleta) nagbansay sa kasingkasing, baga, ug sa gagmay nga pabrika sa enerhiya sulod sa mga selula sa kaunoran. Ang resistance nga ehersisyo (pagbarog gikan sa lingkoranan, gaan nga pabug-at) mohatag sa labing kusog nga senyales aron motukod og protina ang kaunoran. Ang breathing exercise nagbansay sa diaphragm, nga motabang sa pag-ubo ug lawom nga pagginhawa human sa operasyon.Lumagu ya ing laman nung pagawan me dikit a mas dakal kesa king anggaga na, at kaibat bibyan me pamangan ampo pamagpaynawa bang mayap. Kaya pigsalu ning plano ing adwang klasi ning obra. Ing aerobic a ehersisyu (paglakad, pamagbisikleta) sasanayan na ing pusu, baga, ampo deng malating pabrika ning enerhiya king lalam dareng selula ning laman. Ing resistance a ehersisyu (pamipalto ibat king lukluk, magaan a pabigat) ing mamye pekamasikan a senyales bang manyari protina ing laman. Ing breathing exercise sasanayan na ing diaphragm, a tutulung king pamaku at malalam a pamangisnawa kaibat ning operasyun.

DayArawAdlawAldoWhat to doGagawinBuhatonGawanHow much to startGaano karami sa simulaUnsa kadaghan sa sinugdananMakananu kadakal king pamimpisan
Dialysis days (for example Mon/Wed/Fri)Araw ng dialysis (halimbawa Lun/Miy/Biy)Adlaw sa dialysis (pananglitan Lun/Miy/Biy)Aldo ning dialysis (alimbawa Lun/Miy/Bye)Pedal exerciser or leg lifts in the first half of the session, if your unit allows. Rest after.Pedal exerciser o pag-angat ng binti sa unang kalahati ng sesyon, kung pinapayagan ng unit. Magpahinga pagkatapos.Pedal exerciser o pag-alsa sa bitiis sa unang katunga sa sesyon, kung gitugotan sa unit. Pahulay human.Pedal exerciser o pamangatas bitis king mumunang kalahati ning sesyun, nung pipayagan ning unit. Magpaynawa kaibat.10–15 minutes, easy pace10–15 minuto, magaan na bilis10–15 ka minuto, hinay nga dagan10–15 minutu, magaan a bilis
Non-dialysis days (for example Tue/Thu/Sat)Walang dialysis (halimbawa Mar/Huw/Sab)Walay dialysis (pananglitan Mar/Huw/Sab)Alang dialysis (alimbawa Mar/Hwe/Sab)Walk; then chair stands; then light weights or water bottles with the arm that has no fistula.Maglakad; pagkatapos ay pagtayo mula sa upuan; pagkatapos ay magaang na pabigat o bote ng tubig gamit ang braso na walang fistula.Paglakaw; dayon pagbarog gikan sa lingkoranan; dayon gaan nga pabug-at o botelya sa tubig gamit ang bukton nga walay fistula.Maglakad; kaibat pamipalto ibat king lukluk; kaibat magaan a pabigat o bote ning danum gamit ing gamat a alang fistula.Walk 10 minutes; 2 sets of 8 chair stands; 2 sets of 10 arm curlsLakad 10 minuto; 2 set ng 8 pagtayo; 2 set ng 10 arm curlLakaw 10 ka minuto; 2 ka set sa 8 ka pagbarog; 2 ka set sa 10 ka arm curlLakad 10 minutu; 2 set ning 8 a pamipalto; 2 set ning 10 arm curl
Every dayAraw-arawMatag adlawAldo-aldoSlow deep breathing: breathe in through the nose for 3 seconds, out through pursed lips for 6.Mabagal na malalim na paghinga: huminga sa ilong nang 3 segundo, ilabas sa nakaipit na labi nang 6.Hinay nga lawom nga pagginhawa: ginhawa sa ilong sulod sa 3 segundo, gawas sa gipiot nga ngabil sulod sa 6.Malambang malalam a pamangisnawa: mangisnawa king arung king 3 segundu, ilwal king mekaipit a labi king 6.5 minutes, twice a day5 minuto, dalawang beses sa isang araw5 ka minuto, kaduha sa usa ka adlaw5 minutu, makaduang besis king metung a aldo
One day a weekIsang araw kada linggoUsa ka adlaw matag semanaMetung a aldo kada domingguRest, or an easy family walk.Pahinga, o magaang na paglalakad kasama ang pamilya.Pahulay, o hinay nga paglakaw uban ang pamilya.Pamagpaynawa, o magaan a paglakad kayabe ing pamilya.As you likeAyon sa gustoSumala sa gustoAgpang king buri mu
Weekly plan: pedal on dialysis days, walk, chair stands, and light weights on other days, rest on Sunday, breathing exercises every day.

Your starter week at a glance. Match the days to your own dialysis schedule.Ang iyong panimulang linggo sa isang tingin. Itugma ang mga araw sa sarili mong iskedyul ng dialysis.Ang imong sinugdanang semana sa usa ka tan-aw. Ipahiangay ang mga adlaw sa imong kaugalingong iskedyul sa dialysis.Ing panimulang dominggu mu king metung a lawe. Itugma me reng aldo king sariling iskedyul mu ning dialysis.

How hard, and how to build upGaano kabigat, at paano dadagdaganUnsa ka bug-at, ug unsaon pagdugangMakananu kabayat, at makananu dagdagan

Four steps of a chair stand with arms crossed, and a talk-test meter: just right is when you can talk but not sing.

The chair stand in four steps, and the talk test: you should be able to talk, but not sing.Ang pagtayo mula sa upuan sa apat na hakbang, at ang talk test: dapat kaya mong magsalita, pero hindi kumanta.Ang pagbarog gikan sa lingkoranan sa upat ka lakang, ug ang talk test: kinahanglan makasulti ka, apan dili makakanta.Ing pamipalto ibat king lukluk king apat a makbang, ampo ing talk test: dapat kaya mung manyalita, pero e kumanta.

Special situationsMga espesyal na sitwasyonMga espesyal nga sitwasyonReng espesyal a sitwasyun

Do lift with the other arm, squeeze gently, and feel the buzz; don't use heavy weights, tight straps, or a blood pressure cuff on the fistula arm.

Protect the fistula arm: lift with the other arm, and keep straps and cuffs off it. Leg exercise is fully allowed.Protektahan ang brasong may fistula: gamitin ang kabilang braso sa pagbuhat, at iwasan ang tali at cuff dito. Malayang gawin ang ehersisyo sa binti.Panalipdi ang bukton nga adunay fistula: gamita ang laing bukton sa pagbayaw, ug ayaw butangi og higot ug cuff. Gawasnon ang ehersisyo sa bitiis.Protektan me ing gamat a maki fistula: gamitan me ing aliwang gamat king pamuat, at iwasan ing tali ampo cuff kaniti. Malaya ing ehersisyu king bitis.

Track three numbers each monthItala ang tatlong numero bawat buwanIsulat ang tulo ka numero matag bulanIsulat ing atlung numeru balang bulan

Progress you can see keeps you going. Once a month, on a non-dialysis day, write down: (1) how many times you can stand up from a chair, arms crossed, in 30 seconds; (2) how far you can walk in 6 minutes, or how long it takes to walk 4 meters; and (3) your grip strength, if your clinic has a grip meter. Bring the list to your transplant visits.Ang nakikitang pag-unlad ay nagpapatuloy sa iyo. Isang beses kada buwan, sa araw na walang dialysis, isulat: (1) ilang beses kang makakatayo mula sa upuan, nakakrus ang braso, sa loob ng 30 segundo; (2) gaano kalayo ang kaya mong lakarin sa loob ng 6 minuto, o gaano katagal lakarin ang 4 na metro; at (3) ang lakas ng iyong hawak, kung may grip meter ang klinika. Dalhin ang listahan sa iyong mga transplant visit.Ang makita nga pag-uswag magpadayon kanimo. Kausa matag bulan, sa adlaw nga walay dialysis, isulat: (1) pila ka higayon ka makabarog gikan sa lingkoranan, nakakros ang bukton, sulod sa 30 segundo; (2) unsa kalayo ang imong malakaw sulod sa 6 ka minuto, o unsa kadugay ang paglakaw og 4 ka metros; ug (3) ang kusog sa imong kupot, kung adunay grip meter ang klinika. Dad-a ang lista sa imong mga transplant visit.Ing akakit a pamaglago tuloy na ka. Misan kada bulan, king aldo a alang dialysis, isulat: (1) pilan a besis kang makapalto ibat king lukluk, makakrus ing gamat, king lalam ning 30 segundu; (2) makananu kalayu ing kaya mung lakaran king lalam ning 6 minutu, o makananu kabuyu ing paglakad king 4 metru; at (3) ing sikan ning kapit mu, nung atin grip meter ing klinika. Darang mu ing listahan kareng transplant visit mu.

Eating to build muscle while you waitPagkain para bumuo ng kalamnan habang naghihintayPagkaon aron motukod og kaunoran samtang naghulatPamangan bang manyari laman kabang manaya

Exercise is the signal; protein is the brick. Without enough protein and calories, the body uses muscle as fuel and exercise cannot build anything. People on dialysis need more protein than before dialysis, because dialysis removes amino acids and the body is in a more catabolic (breaking-down) state.Ang ehersisyo ang senyales; ang protina ang ladrilyo. Kung kulang ang protina at calories, ginagamit ng katawan ang kalamnan bilang gasolina at walang mabubuo ang ehersisyo. Ang mga naka-dialysis ay nangangailangan ng mas maraming protina kaysa bago mag-dialysis, dahil inaalis ng dialysis ang amino acid at mas nasa estadong catabolic (pagkasira) ang katawan.Ang ehersisyo ang senyales; ang protina ang bloke. Kung kulang ang protina ug calories, gamiton sa lawas ang kaunoran isip sugnod ug walay matukod ang ehersisyo. Ang mga naka-dialysis nagkinahanglan og mas daghan nga protina kaysa sa wala pa mag-dialysis, tungod kay gikuha sa dialysis ang amino acid ug ang lawas anaa sa mas catabolic (pagkabungkag) nga kahimtang.Ing ehersisyu ing senyales; ing protina ing ladrilyu. Nung kulang ing protina at calories, gamitan ning katawan ing laman antimong gasolina at alang mayari ing ehersisyu. Deng naka-dialysis kailangan da ing mas dakal a protina kesa bayu mag-dialysis, uli ta ilalako ning dialysis ing amino acid at mas atiu king catabolic (pamakalungkag) a kalagayan ing katawan.

Your situationAng iyong sitwasyonAng imong sitwasyonIng sitwasyun muUsual protein targetKaraniwang target na protinaKasagarang target sa protinaKaraniwang target a protinaExample for a 60-kg adultHalimbawa para sa 60-kg na adultoPananglitan alang sa 60-kg nga hamtongAlimbawa para king 60-kg a matua
On hemodialysis, stableNaka-hemodialysis, stableNaka-hemodialysis, stableNaka-hemodialysis, stable1.0–1.2 g/kg/day60–72 g of protein a day60–72 g na protina bawat araw60–72 g nga protina matag adlaw60–72 g a protina balang aldo
On peritoneal dialysis, stableNaka-peritoneal dialysis, stableNaka-peritoneal dialysis, stableNaka-peritoneal dialysis, stable1.0–1.2 g/kg/day60–72 g a day; peritoneal dialysis (PD) also loses protein into the fluid60–72 g bawat araw; nawawalan din ng protina sa fluid ang peritoneal dialysis (PD)60–72 g matag adlaw; mawad-an usab og protina sa fluid ang peritoneal dialysis (PD)60–72 g balang aldo; mawalan ya mu naman protina king fluid ing peritoneal dialysis (PD)
Not yet on dialysisHindi pa naka-dialysisWala pa naka-dialysisE pa naka-dialysisUsually lower, to protect the kidneysKaraniwang mas mababa, para protektahan ang batoKasagaran mas ubos, aron mapanalipdan ang batoKaraniwang mas mababa, bang protektan ing batuDo not raise protein on your own; ask your nephrologist and dietitianHuwag dagdagan ang protina nang mag-isa; itanong sa nephrologist at dietitianAyaw dugangi ang protina nga ikaw ra; pangutana sa nephrologist ug dietitianE mu dagdagan ing protina nung ika mu; ikutang mu king nephrologist ampo dietitian

Energy matters as much as protein: most stable adults on dialysis need about 25 to 35 kilocalories per kilogram a day. Timing helps too. Eating some protein within about an hour after exercise, such as an egg, a piece of fish, or a renal-specific nutrition drink if your team prescribes one, gives the muscle building blocks when it is most ready to use them. In FRAILMar, participants took a protein supplement right after each session.Kasinghalaga ng protina ang enerhiya: karamihan ng stable na adulto sa dialysis ay nangangailangan ng mga 25 hanggang 35 kilocalories kada kilo bawat araw. Nakakatulong din ang tamang oras. Ang pagkain ng kaunting protina sa loob ng mga isang oras pagkatapos mag-ehersisyo, gaya ng itlog, isang piraso ng isda, o renal-specific na nutrition drink kung inireseta ng team, ay nagbibigay sa kalamnan ng materyales kapag ito ay pinakahanda. Sa FRAILMar, uminom ng protein supplement ang mga kalahok pagkatapos ng bawat sesyon.Sama ka importante sa protina ang enerhiya: kadaghanan sa stable nga hamtong sa dialysis nagkinahanglan og mga 25 hangtod 35 ka kilocalories matag kilo matag adlaw. Makatabang usab ang husto nga oras. Ang pagkaon og gamay nga protina sulod sa mga usa ka oras human sa ehersisyo, sama sa itlog, usa ka tipak sa isda, o renal-specific nga nutrition drink kung gireseta sa team, mohatag sa kaunoran og materyales kung kini labing andam. Sa FRAILMar, miinom og protein supplement ang mga partisipante human sa matag sesyon.Antimong kayalaga ning protina ing enerhiya: kadakalan kareng stable a matua king dialysis kailangan da ing manga 25 anggang 35 kilocalories kada kilo balang aldo. Makatulung ya mu naman ing tamang oras. Ing pamangan dikit a protina king lalam ning manga metung a oras kaibat ning ehersisyu, antimo ning ebun, metung a pidasu ning asan, o renal-specific a nutrition drink nung ireseta ning team, mamye materyales king laman nung pekahanda ya. King FRAILMar, minum lang protein supplement deng kayabe kaibat ning balang sesyun.

Filipino protein choices that fit dialysis limitsMga pagpipiliang protinang Pilipino na akma sa limitasyon ng dialysisMga Pilipinong kapilian sa protina nga mohaum sa limitasyon sa dialysisReng Pilipinung pipilian a protina a tugma king limitasyun ning dialysis

FoodPagkainPagkaonPamanganWhy it helpsBakit nakakatulongNganong makatabangNung bakit makatulungWatch out forMag-ingat saPag-amping saMag-ingat king
Egg whites, whole eggsPuti ng itlog, buong itlogPuti sa itlog, tibuok itlogPuti ning ebun, buung ebunHigh-quality protein; egg white is low in phosphorusMataas na kalidad na protina; mababa sa phosphorus ang puti ng itlogTaas nga kalidad nga protina; ubos sa phosphorus ang puti sa itlogMataas a kalidad a protina; mababa king phosphorus ing puti ning ebunYolk adds phosphorus; follow your lab-based limitMay dagdag na phosphorus ang pula; sundin ang limit batay sa labAdunay dugang phosphorus ang pula; sunda ang limit base sa labAtin dagdag a phosphorus ing malutu; tuparan ing limit batay king lab
Fresh fish (bangus, tilapia, galunggong), chicken without skinSariwang isda (bangus, tilapia, galunggong), manok na walang balatPresko nga isda (bangus, tilapia, galunggong), manok nga walay panitSariwang asan (bangus, tilapia, galunggong), manuk a alang balatComplete protein, moderate potassium when boiled or grilledKumpletong protina, katamtamang potassium kapag nilaga o inihawKompleto nga protina, kasarangang potassium kung gilaga o giihawKumpletung protina, katamtamang potassium nung nilaga o inyawPortion size; sauces with soy or patis add saltLaki ng hain; may asin ang sarsang may toyo o patisGidak-on sa bahin; adunay asin ang sarsa nga adunay toyo o patisDagul ning ain; atin asin ing sarsang maki toyo o patis
Tofu (tokwa), mung beans (monggo) in measured portionsTokwa, monggo sa sukat na hainTokwa, monggo sa gisukod nga bahinTokwa, munggu king sukat a ainPlant protein; useful later after transplant tooProtinang galing sa halaman; kapaki-pakinabang din pagkatapos ng transplantProtina gikan sa tanom; magamit usab human sa transplantProtinang ibat king tanaman; mapakinabang ya mu naman kaibat ning transplantMonggo is higher in potassium; ask your dietitian for your portionMas mataas sa potassium ang monggo; itanong sa dietitian ang tamang hainMas taas sa potassium ang monggo; pangutana sa dietitian ang husto nga bahinMas mataas king potassium ing munggu; ikutang mu king dietitian ing tamang ain
Dried and processed meats (tuyo, daing, longganisa, hotdog, canned meat)Tuyo at processed na karne (tuyo, daing, longganisa, hotdog, de-lata)Uga ug processed nga karne (tuyo, daing, longganisa, hotdog, de-lata)Tuyu at processed a karne (tuyo, daing, longganisa, hotdog, de-lata)Convenient, but not a good protein baseMadali, pero hindi magandang batayan ng protinaSayon, apan dili maayong basehan sa protinaMadali, pero e mayap a batayan ning protinaVery high salt and phosphate additives; keep rareNapakaalat at may phosphate additive; bihira lamangKaayo ka asin ug adunay phosphate additive; panagsa raMaalat a maalat at maki phosphate additive; bihira mu
Better protein choices on dialysis are eggs, fresh fish, tilapia, skinless chicken, and tokwa. Tuyo, longganisa, canned meat, and hotdogs should be rare. Eat a little protein after exercise.

Familiar protein foods that build muscle within dialysis limits, and salty ones to keep rare. Ask your dietitian for your daily amount.Mga kilalang pagkaing may protina na bumubuo ng kalamnan sa loob ng limitasyon ng dialysis, at mga maalat na dapat bihira lang. Itanong sa dietitian ang iyong pang-araw-araw na dami.Mga naila nga pagkaon nga adunay protina nga motukod og kaunoran sulod sa limitasyon sa dialysis, ug mga parat nga angay panagsa ra. Pangutana sa dietitian ang imong adlaw-adlaw nga gidaghanon.Reng kilalang pamangan a maki protina a manyari laman king lalam ning limitasyun ning dialysis, ampo reng maalat a dapat bihira mu. Ikutang mu king dietitian ing aldo-aldong dakal mu.

Stress, sleep, mood, and familyStress, tulog, damdamin, at pamilyaStress, tulog, pagbati, ug pamilyaStress, tudtud, pamakiramdam, ampo pamilya

Waiting is hard. The phone may ring at 2 a.m. or not for years. Long-term stress raises cortisol, which breaks down muscle and disturbs sleep, and poor sleep lowers the drive to move. Low mood is common on dialysis and is treatable. Checking your mood is part of prehabilitation, not a side issue, and every transplant candidate should have a psychosocial assessment.Mahirap ang maghintay. Maaaring tumunog ang telepono nang alas-2 ng madaling-araw o hindi sa loob ng ilang taon. Ang matagal na stress ay nagpapataas ng cortisol, na sumisira sa kalamnan at gumugulo sa tulog, at ang kulang na tulog ay nagpapababa ng gana na gumalaw. Karaniwan ang mababang damdamin sa dialysis at nagagamot ito. Bahagi ng prehabilitation ang pagsusuri ng damdamin, hindi ito gilid na usapin, at bawat transplant candidate ay dapat magkaroon ng psychosocial assessment.Lisod ang paghulat. Mahimong motingog ang telepono sa alas-2 sa kaadlawon o dili sulod sa pipila ka tuig. Ang dugay nga stress mopataas sa cortisol, nga mobungkag sa kaunoran ug mogubot sa tulog, ug ang kulang nga tulog mopaubos sa gana sa paglihok. Kasagaran ang ubos nga pagbati sa dialysis ug matambalan kini. Bahin sa prehabilitation ang pagsusi sa pagbati, dili kini kilid nga isyu, ug ang matag transplant candidate kinahanglan adunay psychosocial assessment.Mairap ing manaya. Malyaring tumunug ing telepunu alas-2 ning gatpanapun o ali king lalam ning pilan a banwa. Ing maboyung stress pataasan na ing cortisol, a lungkagan na ing laman at gulwan na ing tudtud, at ing kulang a tudtud pababan na ing gana gumalo. Karaniwan ya ing mababang pamakiramdam king dialysis at agamut ya. Bage ning prehabilitation ing pamanyiasat ning pamakiramdam, ali ya gilid a usapan, at ing balang transplant candidate dapat atin yang psychosocial assessment.

Line-art symbol linking kidney, muscle, heart, and brain in one loop.

Kidney, muscle, heart, and mind are one loop: moving, eating well, and support help all four.Iisang ikot ang bato, kalamnan, puso, at isip: nakakatulong sa apat ang paggalaw, tamang pagkain, at suporta.Usa ka liko ang bato, kaunoran, kasingkasing, ug hunahuna: makatabang sa upat ang paglihok, maayong pagkaon, ug suporta.Metung mung ikut ing batu, laman, pusu, ampo isip: makatulung king apat ing pamaggalo, mayap a pamangan, ampo suporta.

Check in with yourselfSuriin ang sariliSusiha ang kaugalingonSiyasatan me ing sarili mu
⌬
PHQ-9 Depression Screen
Nine questions on mood over the past two weeks.
Open →

Why the gains fade, and how to keep themBakit nawawala ang pakinabang, at paano ito mapapanatiliNganong mawala ang kaayohan, ug unsaon pagpabilin niiniNung bakit mawala ing kapakanan, at makananu yang panatilian

Muscle is expensive for the body to keep. When the exercise signal stops, the body starts trimming it within weeks, and in kidney failure the pull toward breakdown is stronger than usual. That is why the FRAILMar gains faded by 6 months, and why a large Dutch trial of exercise after transplant (the ACT trial) found that benefits seen during 3 months of supervised training were no longer clear at 15 months. The lesson is not that exercise fails. It is that a short program is not enough; the habit is the treatment.Mahal para sa katawan ang pagpapanatili ng kalamnan. Kapag tumigil ang senyales ng ehersisyo, sinisimulan itong bawasan ng katawan sa loob ng ilang linggo, at sa kidney failure mas malakas ang hila patungo sa pagkasira. Kaya nawala ang pakinabang ng FRAILMar pagdating ng 6 na buwan, at kaya natuklasan ng isang malaking trial sa Netherlands tungkol sa ehersisyo pagkatapos ng transplant (ang ACT trial) na ang pakinabang na nakita sa 3 buwang supervised na pagsasanay ay hindi na malinaw pagdating ng 15 buwan. Ang aral ay hindi na pumapalya ang ehersisyo. Ito ay na hindi sapat ang maikling programa; ang ugali mismo ang gamot.Mahal alang sa lawas ang pagpabilin sa kaunoran. Kung mohunong ang senyales sa ehersisyo, sugdan kini pagkunhod sa lawas sulod sa pipila ka semana, ug sa kidney failure mas kusog ang guyod padulong sa pagkabungkag. Mao nga nawala ang kaayohan sa FRAILMar pag-abot sa 6 ka bulan, ug mao nga nakit-an sa usa ka dako nga trial sa Netherlands bahin sa ehersisyo human sa transplant (ang ACT trial) nga ang kaayohan nga nakita sa 3 ka bulan nga supervised nga pagbansay dili na klaro pag-abot sa 15 ka bulan. Ang leksyon dili nga mapakyas ang ehersisyo. Kini mao nga dili igo ang mubo nga programa; ang batasan mismo ang tambal.Mal ya para king katawan ing pamanatili ning laman. Nung tumigil ing senyales ning ehersisyu, pimpisan na yang bawasan ning katawan king lalam ning pilan a dominggu, at king kidney failure mas masikan ing guyud papunta king pamakalungkag. Kaya mewala ing kapakanan ning FRAILMar pamanyabi ning 6 bulan, at kaya akit ning metung a maragul a trial king Netherlands tungkul king ehersisyu kaibat ning transplant (ing ACT trial) a ing kapakanan a akit king 3 bulan a supervised a pamagsanay ali ne malino pamanyabi ning 15 bulan. Ing aral ali ya ing pupalya ing ehersisyu. Iti ya a e sapat ing malagad a programa; ing ugali mismu ing gamot.

Habit cycle: plan the week, move, eat protein, rest and sleep, measure monthly, add a little more, and restart at half after a setback.

Keep the loop turning. After a setback, restart at half and rebuild.Panatilihing umiikot ang siklo. Pagkatapos ng aberya, magsimula sa kalahati at buuin muli.Ipadayon ang liko. Human sa kapakyasan, sugdi sa katunga ug tukora pag-usab.Panatilian yang umikut ing siklo. Kaibat ning aberya, mamimpisan king kalahati at buuan me pasibayu.

After the transplant: a new way of eatingPagkatapos ng transplant: bagong paraan ng pagkainHuman sa transplant: bag-ong paagi sa pagkaonKaibat ning transplant: bayung paralan ning pamangan

A working kidney changes the rules. Many of the potassium, phosphorus, and fluid limits you lived with on dialysis may loosen, and new risks take their place: weight gain (steroids raise appetite), high blood sugar after transplant, high blood pressure, high cholesterol, and infections, because anti-rejection medicines lower your defenses. The diet that protects a new kidney looks much like a heart-healthy diet: more vegetables, fruit, fiber, and plant protein, less salt and processed meat. Your team will tell you which old limits to drop and when, based on your blood tests.Binabago ng gumaganang bato ang mga patakaran. Maaaring lumuwag ang maraming limitasyon sa potassium, phosphorus, at tubig na nakasanayan mo sa dialysis, at may mga bagong panganib na papalit: pagtaba (pinapataas ng steroid ang gana), mataas na asukal pagkatapos ng transplant, mataas na presyon, mataas na kolesterol, at impeksyon, dahil pinahihina ng mga gamot laban sa rejection ang iyong depensa. Ang pagkaing nagpoprotekta sa bagong bato ay halos kahawig ng pagkaing mabuti sa puso: mas maraming gulay, prutas, fiber, at protinang galing sa halaman, mas kaunting asin at processed na karne. Sasabihin ng team kung aling dating limitasyon ang aalisin at kailan, batay sa iyong blood test.Usbon sa nagtrabaho nga bato ang mga lagda. Mahimong moluag ang daghang limitasyon sa potassium, phosphorus, ug tubig nga naandan nimo sa dialysis, ug adunay bag-ong mga peligro nga mopuli: pagtambok (gipataas sa steroid ang gana), taas nga asukal human sa transplant, taas nga presyon, taas nga kolesterol, ug impeksyon, tungod kay gipahuyang sa mga tambal batok sa rejection ang imong depensa. Ang pagkaon nga manalipod sa bag-ong bato halos sama sa pagkaon nga maayo sa kasingkasing: mas daghang utanon, prutas, fiber, ug protina gikan sa tanom, mas gamay nga asin ug processed nga karne. Isulti sa team kung unsang daan nga limitasyon ang tangtangon ug kanus-a, base sa imong blood test.Babaguan ning batung gumagana ing manga patakaran. Malyaring lumuag deng dakal a limitasyun king potassium, phosphorus, at danum a anggaga mu king dialysis, at atin bayung panganib a sumalili: pamagtaba (pataasan ning steroid ing gana), mataas a asukal kaibat ning transplant, mataas a presyun, mataas a kolesterol, ampo impeksyun, uli ta paluyan da reng gamot laban king rejection ing depensa mu. Ing pamangan a protektan ing bayung batu kalupa ne ning pamangan a mayap king pusu: mas dakal a gule, bunga, fiber, ampo protina ibat king tanaman, mas dikit a asin at processed a karne. Sabyan ning team nung nanung dating limitasyun ing ilako at kapilan, batay king blood test mu.

On dialysis, the plate has fluid, potassium, and phosphorus limits; after transplant it shifts to more vegetables, fruit, fiber, and plant protein with less salt.

After transplant, the plate shifts from dialysis limits to a heart-healthy pattern. Your team decides which limits change.Pagkatapos ng transplant, lumilipat ang plato mula sa limitasyon ng dialysis patungo sa pagkaing mabuti sa puso. Ang team ang magpapasya kung aling limitasyon ang magbabago.Human sa transplant, mobalhin ang plato gikan sa limitasyon sa dialysis ngadto sa pagkaon nga maayo sa kasingkasing. Ang team ang modesisyon kung unsang limitasyon ang mausab.Kaibat ning transplant, lilipat ya ing pinggan ibat king limitasyun ning dialysis papunta king pamangan a mayap king pusu. Ing team ing magdesisyun nung nanung limitasyun ing mibago.

Most people find this shift hard. A 2026 Dutch study of 167 recipients, about 5 months after transplant, found that only about 1 in 5 ate enough fruit and only about 1 in 4 ate enough vegetables or fiber. Just 12% got at least half their protein from plants. Recipients of a kidney from a deceased donor ate fewer vegetables, and those taking five or more daily medicines got less of their protein from plants. The diet looked much like that of the general population, which is the point: a transplant does not change eating habits by itself.Karamihan ay nahihirapan sa pagbabagong ito. Natuklasan ng isang pag-aaral noong 2026 sa Netherlands sa 167 recipient, mga 5 buwan pagkatapos ng transplant, na mga 1 lamang sa bawat 5 ang kumakain ng sapat na prutas at mga 1 lamang sa bawat 4 ang kumakain ng sapat na gulay o fiber. 12% lamang ang kumukuha ng kalahati man lang ng kanilang protina mula sa halaman. Mas kaunti ang gulay na kinakain ng mga tumanggap ng bato mula sa namatay na donor, at mas kaunti ang protinang galing sa halaman ng mga umiinom ng lima o higit pang gamot araw-araw. Halos kapareho ng sa pangkalahatang populasyon ang kanilang pagkain, at iyon ang punto: hindi kusang binabago ng transplant ang ugali sa pagkain.Kadaghanan naglisod niini nga kausaban. Nakit-an sa usa ka pagtuon niadtong 2026 sa Netherlands sa 167 ka recipient, mga 5 ka bulan human sa transplant, nga mga 1 lang sa matag 5 ang mikaon og igo nga prutas ug mga 1 lang sa matag 4 ang mikaon og igo nga utanon o fiber. 12% lang ang nakakuha og labing menos katunga sa ilang protina gikan sa tanom. Mas gamay ang utanon nga gikaon sa nakadawat og bato gikan sa namatay nga donor, ug mas gamay ang protina gikan sa tanom sa nag-inom og lima o labaw pa nga tambal matag adlaw. Halos sama sa kinatibuk-ang populasyon ang ilang pagkaon, ug mao kana ang punto: dili kusog nga usbon sa transplant ang batasan sa pagkaon.Kadakalan mairapan king pamaglino a iti. Akit ning metung a pamag-aral kaniting 2026 king Netherlands king 167 a recipient, manga 5 bulan kaibat ning transplant, a manga 1 mu king balang 5 ing mangan sapat a bunga at manga 1 mu king balang 4 ing mangan sapat a gule o fiber. 12% mu ing kukwang kalahati man mu ning protina da ibat king tanaman. Mas dikit ing gule a kakanan dareng tinggap batu ibat king mete a donor, at mas dikit ing protinang ibat king tanaman dareng minum lima o mas dakal a gamot aldo-aldo. Kalupa ne ning king pangkalahatang populasyun ing pamangan da, at ita ing punto: e kusang babaguan ning transplant ing ugali king pamangan.

Bar chart: share of 167 kidney transplant recipients meeting four dietary targets: fruit 22%, vegetables 28%, fiber 26%, plant-to-total protein ratio 12%.

Few people met healthy-eating targets about 5 months after transplant: fruit 22%, vegetables 28%, fiber 26%, and plant protein 12% (Doorenbos et al., 2026; Dutch targets).Kaunti ang nakaabot sa target ng malusog na pagkain mga 5 buwan pagkatapos ng transplant: prutas 22%, gulay 28%, fiber 26%, at protinang halaman 12% (Doorenbos et al., 2026; target ng Netherlands).Gamay ra ang nakaabot sa target sa himsog nga pagkaon mga 5 ka bulan human sa transplant: prutas 22%, utanon 28%, fiber 26%, ug protina sa tanom 12% (Doorenbos et al., 2026; target sa Netherlands).Dikit mu ing miabut king target ning masalusung pamangan manga 5 bulan kaibat ning transplant: bunga 22%, gule 28%, fiber 26%, ampo protinang tanaman 12% (Doorenbos et al., 2026; target ning Netherlands).

Food safety and medicine safetyKaligtasan sa pagkain at gamotKaluwasan sa pagkaon ug tambalKaligtasan king pamangan at gamot

With tacrolimus or cyclosporine, avoid pomelo (suha), grapefruit, herbal capsules such as turmeric, and raw or undercooked food unless your transplant team approves.

A card for the fridge door: foods and supplements to avoid with tacrolimus or cyclosporine unless your team says yes.Kard para sa pinto ng ref: mga pagkain at supplement na dapat iwasan kapag umiinom ng tacrolimus o cyclosporine maliban kung pumayag ang team.Kard alang sa pultahan sa ref: mga pagkaon ug supplement nga angay likayan kung nag-inom og tacrolimus o cyclosporine gawas kung motugot ang team.Kard para king pasbul ning ref: reng pamangan ampo supplement a dapat iwasan nung minum tacrolimus o cyclosporine nung e pumayag ing team.

Build your question list for the next visitBuuin ang iyong listahan ng tanong para sa susunod na pagbisitaHimoa ang imong lista sa pangutana alang sa sunod nga pagbisitaBuuan me ing listahan ning kutang mu para king susunod a pamibisita

Tick the questions that matter to you, then print or copy the list and bring it to your nephrologist or transplant team.Markahan ang mga tanong na mahalaga sa iyo, pagkatapos ay i-print o kopyahin ang listahan at dalhin sa iyong nephrologist o transplant team.Markahi ang mga pangutana nga importante kanimo, unya i-print o kopyaha ang lista ug dad-a sa imong nephrologist o transplant team.Markan me ing kutang a mayalaga keka, kaibat i-print o kopyan me ing listahan at darang me king nephrologist o transplant team mu.

Common questionsMga karaniwang tanongKasagarang mga pangutanaReng karaniwang kutang

Will exercising get me a kidney sooner?Mas mapapabilis ba ang pagkuha ko ng bato kung mag-eehersisyo ako?Mas mapadali ba ang pagkuha nako og bato kung mag-ehersisyo ko?Mas mapadali ya ing pamikua ku batu nung mag-ehersisyu ku?
Not directly. Kidneys are allocated by blood type, tissue match, waiting time, and other rules, not fitness. But being fit can help you be listed and stay listed. People with low physical function are less likely to be listed, and if a kidney is offered, being strong helps you be ready to accept it.Hindi direkta. Ibinibigay ang bato batay sa blood type, tissue match, tagal ng paghihintay, at iba pang patakaran, hindi sa fitness. Pero nakakatulong ang pagiging fit para mailagay at manatili sa listahan. Mas malamang na hindi mailista ang may mahinang pisikal na kakayahan, at kapag may inalok na bato, nakakatulong ang lakas para handa kang tanggapin ito.Dili direkta. Gihatag ang bato base sa blood type, tissue match, gidugayon sa paghulat, ug uban pang lagda, dili sa fitness. Apan makatabang ang pagkahimsog aron mabutang ug magpabilin sa lista. Mas lagmit nga dili malista ang huyang og pisikal nga abilidad, ug kung adunay gitanyag nga bato, makatabang ang kusog aron andam ka nga dawaton kini.E direktu. Ibye la reng batu batay king blood type, tissue match, kabuyu ning pamanaya, at aliwang patakaran, ali king fitness. Pero makatulung ing pamagbalang fit bang miyabe at manatili ka king listahan. Mas malyaring e mailista ing malunus ing pisikal a kayabe, at nung atin ialuk a batu, makatulung ing sikan bang handa ka tanggapan.
Is it safe to exercise with a fistula?Ligtas bang mag-ehersisyo kahit may fistula?Luwas ba ang pag-ehersisyo bisan adunay fistula?Ligtas ya ing mag-ehersisyu maski atin kang fistula?
Yes, with care. Use the other arm for weights, avoid tight straps or pressure on the fistula arm, and check the thrill (buzz) after exercise. Leg exercise is fully allowed.Oo, nang may pag-iingat. Gamitin ang kabilang braso sa pabigat, iwasan ang masikip na tali o diin sa brasong may fistula, at damhin ang thrill (pag-ugong) pagkatapos mag-ehersisyo. Malayang gawin ang ehersisyo sa binti.Oo, uban ang pag-amping. Gamita ang laing bukton sa pabug-at, likayi ang hugot nga higot o pressure sa bukton nga adunay fistula, ug batia ang thrill (pagkurog) human sa ehersisyo. Gawasnon ang ehersisyo sa bitiis.Wa, a maki pamag-ingat. Gamitan me ing aliwang gamat king pabigat, iwasan ing masikip a tali o diin king gamat a maki fistula, at damdaman me ing thrill (pamag-ugung) kaibat ning ehersisyu. Malaya ing ehersisyu king bitis.
Can I exercise on dialysis days?Maaari ba akong mag-ehersisyo sa araw ng dialysis?Mahimo ba ko mag-ehersisyo sa adlaw sa dialysis?Malyari ku bang mag-ehersisyu king aldo ning dialysis?
Yes. Pedaling or leg lifts in the first half of a session is a good time, when blood pressure is steadier. Avoid hard exercise right after dialysis, when you may feel washed out or dizzy.Oo. Magandang oras ang pag-pedal o pag-angat ng binti sa unang kalahati ng sesyon, kapag mas stable ang presyon. Iwasan ang mabigat na ehersisyo kaagad pagkatapos ng dialysis, kapag maaaring pagod o nahihilo ka.Oo. Maayong oras ang pag-pedal o pag-alsa sa bitiis sa unang katunga sa sesyon, kung mas stable ang presyon. Likayi ang bug-at nga ehersisyo dayon human sa dialysis, kung mahimong kapoy o malipong ka.Wa. Mayap a oras ing pamedal o pamangatas bitis king mumunang kalahati ning sesyun, nung mas stable ing presyun. Iwasan ing mabayat a ehersisyu kaibat dapat ning dialysis, nung malyaring mapagal ka o mangalu.
I am over 65. Is it too late?Lampas 65 na ako. Huli na ba?Lapas na ko sa 65. Ulahi na ba?Lampas ne ku 65. Mabanta na?
No. Older adults gain strength from training too, and frail participants in FRAILMar improved. Age alone does not rule out a transplant; your overall health and fitness matter more.Hindi. Lumalakas din ang matatanda sa pagsasanay, at gumaling ang mga frail na kalahok sa FRAILMar. Hindi hadlang ang edad lamang sa transplant; mas mahalaga ang iyong kabuuang kalusugan at fitness.Dili. Mokusog usab ang mga tigulang sa pagbansay, ug miuswag ang mga frail nga partisipante sa FRAILMar. Dili babag ang edad lang sa transplant; mas importante ang imong kinatibuk-ang kahimsog ug fitness.Ali. Sumikan la mu naman deng matua king pamagsanay, at miyayap la deng frail a kayabe king FRAILMar. E arang ing edad mu pamu king transplant; mas mayalaga ing kabuuang kasalusan at fitness mu.
I cannot afford a gym or a program. What can I do?Hindi ko kaya ang gym o programa. Ano ang magagawa ko?Dili nako makaya ang gym o programa. Unsa ang akong mahimo?E ku kaya ing gym o programa. Nanu ing agawa ku?
Almost everything in the starter plan needs only a sturdy chair, two water bottles, and a safe place to walk. A family member can count and keep you company. Home programs reach more people, but people drop out more often, so a buddy and a written log matter even more.Halos lahat sa panimulang plano ay nangangailangan lamang ng matibay na upuan, dalawang bote ng tubig, at ligtas na lugar para maglakad. Maaaring magbilang at sumama ang isang kapamilya. Mas maraming naaabot ang home program, pero mas madalas tumigil ang mga tao, kaya mas mahalaga ang kasama at nakasulat na tala.Halos tanan sa sinugdanang plano nagkinahanglan lang og lig-on nga lingkoranan, duha ka botelya sa tubig, ug luwas nga lugar sa paglakaw. Ang usa ka membro sa pamilya makaihap ug makauban. Mas daghan ang maabot sa home program, apan mas kanunay mohunong ang mga tawo, mao nga mas importante ang kauban ug sinulat nga talaan.Kalupan eganaga king panimulang plano kailangan na mu ing matibe a lukluk, adwang bote ning danum, ampo ligtas a lugal bang maglakad. Malyaring magbilang at makiyabe ing metung a kapamilya. Mas dakal ing abutan ning home program, pero mas maralas tumigil deng tau, kaya mas mayalaga ing kayabe ampo misulat a tala.

Frailty in transplant candidates: prevalence, prognosis, measurement

Bottom line. Physical frailty is common on the kidney transplant (KT) waiting list, independently associated with waitlist mortality, lower likelihood of listing, and post-transplant death, and measurable at the bedside in under 5 minutes. Whether it is causal for post-transplant outcomes, and therefore whether reversing it changes those outcomes, remains unproven.

Physiology first. Frailty is loss of physiologic reserve across systems. In kidney failure, skeletal muscle protein balance tips toward net catabolism through several converging mechanisms: metabolic acidosis activates the ubiquitin–proteasome pathway; chronic inflammation (interleukin-6, tumor necrosis factor-α) and insulin resistance blunt anabolic signaling through Akt (protein kinase B) and mTOR (mechanistic target of rapamycin); myostatin is upregulated; amino acids (roughly 6–12 g per hemodialysis session) are lost into dialysate; anorexia lowers intake; and dialysis-day inactivity removes the mechanical stimulus. The phenotype that results, low grip, slow gait, exhaustion, low activity, and weight loss, is the clinical readout of that negative balance. Muscle quality matters as well as quantity: in a 2025 two-center cohort of 608 recipients, computed tomography (CT)-defined myosteatosis, not sarcopenia, was associated with all-cause graft loss and death in the US cohort (adjusted hazard ratio [aHR] 1.78 and 2.35), although not in the Dutch cohort.

Mechanism figure: acidosis, inflammation, insulin resistance, myostatin, dialysate amino-acid loss, and inactivity drive muscle breakdown; resistance exercise and protein after sessions push synthesis.

Converging drivers of uremic muscle wasting, and the levers prehabilitation pulls. Strength and muscle gains are shown in a randomized trial; transplant outcomes are not yet tested.

Prevalence and prognosis

StudyPopulationFindingCertainty
Haugen 20204,616 candidates (multicenter cohort) projected to the US registry13.3% frail (Fried ≥3) at evaluation; projected national prevalence 16.4% (14.4–18.4%), about 91,738 candidatesCohort plus registry modeling
FRAILMar (Pérez-Sáez 2025)121 waitlisted, Spain, mean age 6340% had Fried score ≥2, the trial's lower frailty threshold; not comparable with ≥3 estimatesSingle-center baseline; consenting volunteers
Huang 20252,708 candidates, 2 US centersLow activity 40%, low physical function (gait speed) 16%, high physical burden 54%. Low function: listing aHR 0.54 (0.45–0.64); waitlist mortality adjusted sub-hazard ratio 1.83 (1.30–2.58). Physical burden discriminated best (C-statistic 0.69)Prospective cohort; association
McAdams-DeMarco 2015537 recipients, frailty at KT5-year survival 91.5% non-frail, 86.0% intermediately frail, 77.5% frail; adjusted HR for death 2.17 (1.01–4.65)Single-center cohort; wide CI
Karnabi 2024 (systematic review)50 studies, 36 instrumentsFrailty and low function consistently associated with mortality; heterogeneity prevented poolingObservational synthesis

The lower boundary of the McAdams-DeMarco confidence interval (1.01) is a reminder that single-center frailty estimates are imprecise. Every row above is associational: frail candidates carry more comorbidity, longer dialysis vintage, and worse cardiopulmonary reserve, so residual confounding is likely.

What the guideline says

The KDIGO (Kidney Disease: Improving Global Outcomes) 2020 guideline on the evaluation and management of candidates for kidney transplantation advises against excluding candidates on age alone and instead weighing age in the context of comorbidities, including frailty (Section 2), and lists frailty with body habitus among surgical-candidacy assessments (Section 7). It does not mandate a specific instrument or a frailty threshold for exclusion. Grades for these statements are given in the full report and are not restated here. In practice, use frailty to target optimization, not as a gate.

Choosing an instrument

ToolComponentsTimeBest use
Fried Physical Frailty PhenotypeGrip, 4.5-m gait, exhaustion, activity, weight loss; ≥3 frail, 1–2 prefrail~5 min with dynamometerMost transplant-validated; FRAILMar stratified on it
Short Physical Performance Battery (SPPB)Balance, 4-m gait, 5 chair stands (0–12)~5 min, no equipmentSerial tracking of response to prehabilitation
Clinical Frailty Scale (CFS)Judgment-based 1–9<1 minTriage; less sensitive to change
Grip strength, gait speed aloneSingle measures<2 minQuick serial monitoring in the dialysis unit

Different tools label different people as frail, so pick one and use it serially. Weight loss and exhaustion are the Fried criteria most confounded by fluid shifts and uremia; a 2026 survey of 179 Spanish nephrologists rated them least useful in kidney failure.

What the prehabilitation evidence actually shows

The editorial by Lorenz and colleagues in the Journal of Renal Nutrition (2026) frames prehabilitation as multimodal: exercise, nutritional optimization, and psychological support. The evidence base, however, is still mostly small, exercise-only, and built on surrogate endpoints. The American Society of Transplantation and the European Society for Organ Transplantation (ESOT, 2023) have issued consensus statements supporting prehabilitation, and a 2025 review describes it as a valuable perioperative intervention, while calling for multicenter randomized controlled trials (RCTs) before guidelines can be written (Kirkman 2025). FRAILMar was published with an accompanying editorial (Weaver, Orandi, and McAdams-DeMarco 2025) that places it in this context.

StudyDesign / nInterventionKey resultsMain limitation
McAdams-DeMarco 2019Pilot, n=24 enrolled (18 participated; 17% of eligible)Weekly center-based physical therapy plus home exerciseAccelerometer activity +64% at 2 months; length of stay 5 vs 10 days in 5 transplanted participants vs matched controls (RR 0.69, 0.50–0.94)Non-randomized; n=5 for the outcome
Lorenz 2024Two-center pilot, n=15Home-based individualized prescription plus 8 weekly calls60% completed; no unanticipated adverse eventsFeasibility only
Bartlett 2025Randomized, n=29 analyzed (23 vs 6)Supervised resistance training 1 h, 2×/week, 12 monthsSPPB 5.2→7.2; sit-to-stand in 30 s 8.0→16.2; grip 14.3→17.4 kg; muscle fiber diameter +18.6 μm, mitochondrial markers improvedControl arm under-enrolled; within-group analysis
FRAILMar 2025 (Pérez-Sáez)RCT, n=121; 106 completed24 sessions (1 h, 3×/week, 8 weeks, in person or by video): aerobic, resistance, inspiratory muscle training; protein supplement after each sessionMaximal workload on cardiopulmonary exercise testing (CPET) +12.8 W (3.4–22.2); grip +1.8 kg (0.7–2.8); rectus femoris thickness on ultrasound +1.2 mm (0.3–2.0); respiratory muscle strength improved; frail subgroup also improved. No significant effect on VO₂ max, 6-minute walk distance, or frailty statusSingle center; surrogate endpoints; multiplicity; one-third of eligible declined; gains waned by 6 months
Tsuchida 2026 (J Ren Nutr)Meta-analysis, 5 RCTs, n=339, nondialysis CKD G3–G5Combined exercise plus nutritionPeak oxygen uptake (VO₂ peak) +2.70 mL/kg/min (1.22–4.18); no change in kidney functionFew trials, heterogeneity, risk of bias
Uno 2026 (Clin Nutr ESPEN)Meta-analysis, 8 trials, 231 hemodialysis patientsCombined nutrition plus exercise vs nutrition alone6-minute walk +45 m (12.6–77.8); gait speed +0.09 m/s; Timed Up and Go −1.44 s; no effect on lean mass, intake, or quality of lifeGrading of Recommendations, Assessment, Development and Evaluation (GRADE) certainty very low for all outcomes
ACT 2024 (Knobbe), post-transplantMulticenter RCT, n=2213 months supervised exercise ± 15 months dietary counselingPhysical functioning improved at 3 months (exercise arm), not at 15 months; safeOpen label; benefit not sustained
FRAILMar effects with 95% confidence intervals: workload +12.8 W (3.4–22.2), grip +1.8 kg (0.7–2.8), rectus femoris +1.2 mm (0.3–2.0); no significant change in VO2 max, 6-minute walk, or frailty status.

FRAILMar 8-week effects versus usual care, point estimates with 95% confidence intervals (Pérez-Sáez et al., 2025). Each outcome has its own axis and unit.

Appraisal

What is established: structured exercise improves exercise capacity, strength, and muscle size in waitlisted candidates, including frail ones (strong evidence for surrogates from one adequately sized RCT plus consistent smaller studies). What is suggested: shorter length of stay, from a five-patient pilot comparison, and better tolerance of surgery, by extrapolation from non-transplant surgery. What is not shown: any effect on delayed graft function, complications, readmission, graft survival, or mortality. As Lorenz and colleagues note, no RCT has yet examined post-transplant outcomes at all. The FRAILMar protocol pre-specified a 90-day post-transplant composite endpoint; that analysis, which depends on how many participants are transplanted, has not been reported. FRAILMar also did not move VO₂ max, 6-minute walk distance, or frailty status, so its gains are in strength and muscle rather than whole-body aerobic fitness or frailty category.

Magnitude matters. A 12.8-W gain on CPET is a modest absolute change, and a 1.8-kg grip gain is smaller than the changes usually considered clinically meaningful in older adults. Whether these translate into fewer falls or faster post-operative mobilization is a mechanistic inference. Non-transplant surgery tempers expectations further. A systematic review of 23 RCTs (2,475 patients) in colorectal cancer surgery found moderate-certainty evidence that preoperative nutritional supplementation reduces infectious complications (relative risk 0.65), but only low-certainty evidence for shorter length of stay (as summarized by Lorenz 2026). The largest pragmatic trial in frail patients tested coach-supported, home-based multimodal prehabilitation in 847 adults aged 60 or older with Clinical Frailty Scale ≥4 across 13 Canadian centers (McIsaac 2026). After a median 4 weeks, it found no difference in 30-day disability (adjusted mean difference −1.4) or complications (50.1% vs 47.7%; adjusted odds ratio 1.05); only participants completing more than 75% of prescribed exercise reported less disability. Frame prehabilitation accordingly: a safe intervention with proven functional benefit and unproven transplant-outcome benefit.

Evidence tiers: strength, grip, muscle thickness, and breathing muscles improved; aerobic capacity, walk distance, and frailty status did not change; transplant outcomes not yet tested.

Three tiers of evidence: improved in a randomized trial, unchanged in that trial, and not yet tested in transplant trials.

Prescribing prehabilitation: dose, nutrition, mind, and timing

Practical pathway for a waitlisted candidate
1
Screen at listing and every 3–6 months: Fried phenotype or SPPB, grip, 4-m gait, 30-s sit-to-stand; nutrition screen; Patient Health Questionnaire-9 (PHQ-9).
2
Clear for exercise: review cardiac symptoms and existing cardiac work-up (candidates already undergo cardiac evaluation per KDIGO 2020). Defer or supervise for unstable angina, decompensated heart failure, uncontrolled arrhythmia, pre-dialysis potassium above ~6.0 mmol/L, or uncontrolled blood pressure.
3
Exercise dose: moderate-intensity aerobic work (rating of perceived exertion [RPE] 12–14 on the Borg 6–20 scale) building to 150 min/week (KDIGO 2024, grade 1D); resistance training of major lower-limb groups 2–3×/week, 1–3 sets of 8–12 repetitions; inspiratory muscle training with a threshold device, as in FRAILMar; daily balance work if falls risk. Intradialytic cycling in the first half of sessions is the most scalable delivery for hemodialysis patients.
4
Nutrition: hemodialysis 1.0–1.2 g/kg/day protein (KDOQI 2020, grade 1C) and peritoneal dialysis 1.0–1.2 g/kg/day (OPINION); energy 25–35 kcal/kg/day (OPINION). Give protein within ~1 hour after sessions; FRAILMar used a supplement after each session. For non-dialysis candidates, KDOQI recommends 0.55–0.60 g/kg/day (1A) when metabolically stable (0.6–0.8 g/kg/day with diabetes, OPINION); in a frail, pre-emptive candidate the trade-off between preserving residual function and reversing sarcopenia is a judgment call, and in our practice rarely justifies exceeding ~0.8 g/kg/day without dietitian supervision. Correct metabolic acidosis, which itself drives proteolysis.
5
Mind: psychosocial assessment for all candidates (KDIGO 2020); treat depression and insomnia; use motivational interviewing and family involvement for adherence.
6
Maintain, re-test, re-intensify: after any intensive block, move to a maintenance prescription with monthly measurements; re-intensify after hospitalization or when a transplant date approaches.
Pathway: screen, check safety, choose an intensive block before a living-donor date or ongoing maintenance for deceased-donor waits, then re-measure monthly and re-intensify after setbacks.

Printable pathway: screen, clear, choose a living-donor intensive block or deceased-donor maintenance, then re-measure monthly.

Center-based or home-based?

Center-basedHome-basedIntradialytic
ReachLow (travel, cost, time on top of 12 h/week of dialysis)HighHigh for hemodialysis patients
Adherence / attritionBestPoorer; higher attrition (Lorenz 2024: 60% completion)Good when staff-led
Dose control and safetySupervised progressionSelf-reportedMonitored, but limited to cycling and light resistance
Fit for the PhilippinesLimited to tertiary centersFeasible with family supportMost scalable: low-cost pedal exercisers
Center-based programs give the best supervision but are hard to reach; home programs reach more people but more drop out; programs during dialysis use chair time, are nurse-supervised, and cost little.

Three delivery models compared. Intradialytic delivery is the most scalable option for Philippine hemodialysis units.

The timing problem

Non-transplant prehabilitation runs 2–6 weeks before a scheduled operation. The ESOT consensus recommends offering prehabilitation from waitlisting until surgery, but longer programs carry poorer adherence and higher attrition. Because the frailest patients are often never listed, starting prehabilitation before transplant evaluation may matter most for access. Deceased-donor waiting is unpredictable and can last years, and FRAILMar shows that an 8-week block decays by 6 months. Two practical responses follow. For deceased-donor candidates, treat prehabilitation as an always-on maintenance program embedded in dialysis care, with intensification during reactivation or when the candidate nears the top of the list. For living-donor transplants, the surgery date is known: this is the cleanest window for a classic 6–8-week intensive block, and the best place to start a local program.

Assessment without follow-through does not change outcomes

The GOAL cluster randomized trial (Logan et al., Kidney International 2026) tested a single outpatient comprehensive geriatric assessment (CGA) in 240 frail adults aged 65 or older across 15 Australian kidney clinics (mean age 77; about one-third on dialysis). Frailty was defined by a Frailty Index above 0.25. A one-time CGA without structured follow-up did not improve goal attainment or 12-month outcomes. The accompanying commentary by Nixon argued that the assessment must be tied to an intervention pathway.

GOAL did not study transplant candidates, and CGA is not prehabilitation. Its lesson transfers anyway: measuring frailty at listing is not an intervention. A frailty score that lives only in the transplant work-up file will not move. Build the pathway first (who prescribes exercise, who delivers it, who re-measures, and how results reach the transplant team), then screen.

After transplant: diet quality, determinants, and drug–food interactions

In the Active Care after Transplantation (ACT) study cohort, 167 kidney transplant recipients (40% female, mean age 51.9 years, median 147 days post-transplant) completed 3-day food diaries (Doorenbos et al., 2026). Adherence to Dutch food-based guidelines was low: fruit ≥200 g/day 22%, vegetables ≥200 g/day 28%, fiber ≥25 g/day 26%, plant-to-total protein ratio ≥0.50 12%. Intake resembled the general population, slightly better for salt, red meat, and sugary drinks. Deceased-donor transplantation was associated with lower vegetable intake (standardized β −0.45, 95% CI −0.75 to −0.14), and polypharmacy (≥5 daily medicines) with a lower plant-to-total protein ratio (standardized β −0.43, −0.82 to −0.05). The targets are Dutch and the cohort is European; apply them to Filipino diets as directional, not numeric, goals.

Why it matters mechanistically. Post-transplant cardiometabolic risk is driven by glucocorticoid-induced appetite and insulin resistance, calcineurin-inhibitor effects on islet function and lipids, and weight regain once uremic anorexia lifts. A Mediterranean-style pattern targets these pathways; KDOQI 2020 suggests it may improve lipid profiles in recipients (grade 2C). Plant protein and fiber add potassium and alkali load, which are now usually tolerated with a functioning graft.

Drug–food interactions to teach before discharge

With tacrolimus or cyclosporine, avoid pomelo (suha), grapefruit, herbal capsules such as turmeric, and raw or undercooked food unless the transplant team approves.

Patient handout card for discharge teaching on calcineurin-inhibitor food interactions and food safety.

Making it work in Philippine practice

Most Filipino transplant candidates are on in-center hemodialysis three times weekly, often with long travel times and out-of-pocket costs, which makes a separate center-based program unrealistic for many. The pragmatic model is dialysis-unit-embedded prehabilitation:

Coverage: the Philippine Health Insurance Corporation (PhilHealth) benefit packages for kidney transplantation are described in the PhilHealth Z Benefit guide. We have not verified a dedicated benefit for pre-transplant rehabilitation; confirm current coverage with the facility's PhilHealth office before promising it to patients.

Open questions

  1. Transplant outcomes: does prehabilitation reduce delayed graft function, complications, length of stay, readmission, or mortality? Adequately powered multicenter RCTs are needed (the FRAILMar 90-day composite and the Dutch PreCareTx trial of a 12-week tailored home program with a 12-week maintenance phase are steps in this direction).
  2. Timing and maintenance: what is the minimum effective maintenance dose, and how should programs intensify as transplant approaches?
  3. Delivery: how can home and intradialytic models reach the one-third who decline center-based programs without losing adherence?
  4. Nutrition: the optimal protein dose and timing for frail non-dialysis candidates, where kidney-protective restriction and anabolic needs conflict.
  5. Measurement: which frailty instrument best predicts transplant outcomes and responds to intervention? Simple patient-reported physical burden may outperform performance tests for risk prediction.
  6. Equity: frailty is used to decline listing; prehabilitation may be a route to fairer access if it converts "not yet" into "listed."
Glossary & abbreviationsTalahulugan at mga daglatTalaan sa mga pulong ug daglatTalatinigan ampo reng daglat terms used in this guide

Abbreviations

ACT
Active Care after Transplantation, a Dutch study program of lifestyle care after kidney transplant.Active Care after Transplantation, a Dutch study program of lifestyle care after kidney transplant.Active Care after Transplantation, a Dutch study program of lifestyle care after kidney transplant.Active Care after Transplantation, a Dutch study program of lifestyle care after kidney transplant.
aHR
Adjusted hazard ratio: a hazard ratio corrected for other differences between groups.Adjusted hazard ratio: a hazard ratio corrected for other differences between groups.Adjusted hazard ratio: a hazard ratio corrected for other differences between groups.Adjusted hazard ratio: a hazard ratio corrected for other differences between groups.
CFS
Clinical Frailty Scale, a 1-to-9 judgment-based frailty score.Clinical Frailty Scale, a 1-to-9 judgment-based frailty score.Clinical Frailty Scale, a 1-to-9 judgment-based frailty score.Clinical Frailty Scale, a 1-to-9 judgment-based frailty score.
CGA
Comprehensive geriatric assessment: a whole-person review by a geriatrician.Comprehensive geriatric assessment: a whole-person review by a geriatrician.Comprehensive geriatric assessment: a whole-person review by a geriatrician.Comprehensive geriatric assessment: a whole-person review by a geriatrician.
CI
Confidence interval: the range of values compatible with the data.Confidence interval: saklaw ng mga halagang tugma sa datos.Confidence interval: sakup sa mga numero nga mohaum sa datos.Confidence interval: sakup dareng numeru a tugma king datos.
CKD
Chronic kidney disease.Chronic kidney disease.Chronic kidney disease.Chronic kidney disease.
CPET
Cardiopulmonary exercise testing: a treadmill or bike test that measures heart, lung, and muscle capacity.Cardiopulmonary exercise testing: a treadmill or bike test that measures heart, lung, and muscle capacity.Cardiopulmonary exercise testing: a treadmill or bike test that measures heart, lung, and muscle capacity.Cardiopulmonary exercise testing: a treadmill or bike test that measures heart, lung, and muscle capacity.
CT
Computed tomography.Computed tomography.Computed tomography.Computed tomography.
EPTS
Estimated Post-Transplant Survival score.Estimated Post-Transplant Survival score.Estimated Post-Transplant Survival score.Estimated Post-Transplant Survival score.
GRADE
Grading of Recommendations, Assessment, Development and Evaluation: a system for rating certainty of evidence.Grading of Recommendations, Assessment, Development and Evaluation: a system for rating certainty of evidence.Grading of Recommendations, Assessment, Development and Evaluation: a system for rating certainty of evidence.Grading of Recommendations, Assessment, Development and Evaluation: a system for rating certainty of evidence.
HR
Hazard ratio: how much faster an event happens in one group than another; not a probability.Hazard ratio: kung gaano kabilis nangyayari ang isang pangyayari sa isang grupo kumpara sa iba; hindi ito tsansa.Hazard ratio: kung unsa ka paspas mahitabo ang usa ka hitabo sa usa ka grupo kumpara sa lain; dili kini tsansa.Hazard ratio: nung makananu kabilis milyari ing metung a bage king metung a grupu kumpara king aliwa; ali ya tsansa.
KDIGO
Kidney Disease: Improving Global Outcomes, the international kidney guideline organization.Kidney Disease: Improving Global Outcomes, the international kidney guideline organization.Kidney Disease: Improving Global Outcomes, the international kidney guideline organization.Kidney Disease: Improving Global Outcomes, the international kidney guideline organization.
KDOQI
Kidney Disease Outcomes Quality Initiative of the US National Kidney Foundation.Kidney Disease Outcomes Quality Initiative of the US National Kidney Foundation.Kidney Disease Outcomes Quality Initiative of the US National Kidney Foundation.Kidney Disease Outcomes Quality Initiative of the US National Kidney Foundation.
KT
Kidney transplant or kidney transplantation.Kidney transplant or kidney transplantation.Kidney transplant or kidney transplantation.Kidney transplant or kidney transplantation.
MET
Metabolic equivalent of task: a unit of exercise intensity.Metabolic equivalent of task: a unit of exercise intensity.Metabolic equivalent of task: a unit of exercise intensity.Metabolic equivalent of task: a unit of exercise intensity.
mTOR
Mechanistic target of rapamycin, a cell switch that turns on muscle protein building.Mechanistic target of rapamycin, a cell switch that turns on muscle protein building.Mechanistic target of rapamycin, a cell switch that turns on muscle protein building.Mechanistic target of rapamycin, a cell switch that turns on muscle protein building.
PD
Peritoneal dialysis.Peritoneal dialysis.Peritoneal dialysis.Peritoneal dialysis.
PHQ-9
Patient Health Questionnaire-9, a nine-question depression screen.Patient Health Questionnaire-9, a nine-question depression screen.Patient Health Questionnaire-9, a nine-question depression screen.Patient Health Questionnaire-9, a nine-question depression screen.
PreCareTx
PREhabilitation of CAndidates for REnal Transplantation, a Dutch randomized trial.PREhabilitation of CAndidates for REnal Transplantation, a Dutch randomized trial.PREhabilitation of CAndidates for REnal Transplantation, a Dutch randomized trial.PREhabilitation of CAndidates for REnal Transplantation, a Dutch randomized trial.
RCT
Randomized controlled trial.Randomized controlled trial.Randomized controlled trial.Randomized controlled trial.
RPE
Rating of perceived exertion, the Borg 6–20 effort scale.Rating of perceived exertion, the Borg 6–20 effort scale.Rating of perceived exertion, the Borg 6–20 effort scale.Rating of perceived exertion, the Borg 6–20 effort scale.
RR
Relative risk or rate ratio.Relative risk or rate ratio.Relative risk or rate ratio.Relative risk or rate ratio.
SARC-F
Strength, Assistance with walking, Rising from a chair, Climbing stairs, Falls: a sarcopenia screening questionnaire.Strength, Assistance with walking, Rising from a chair, Climbing stairs, Falls: a sarcopenia screening questionnaire.Strength, Assistance with walking, Rising from a chair, Climbing stairs, Falls: a sarcopenia screening questionnaire.Strength, Assistance with walking, Rising from a chair, Climbing stairs, Falls: a sarcopenia screening questionnaire.
SPPB
Short Physical Performance Battery: balance, gait speed, and chair-stand tests scored 0 to 12.Short Physical Performance Battery: balance, gait speed, and chair-stand tests scored 0 to 12.Short Physical Performance Battery: balance, gait speed, and chair-stand tests scored 0 to 12.Short Physical Performance Battery: balance, gait speed, and chair-stand tests scored 0 to 12.
VO₂ peak
Peak oxygen uptake: the most oxygen the body can use during maximal exercise.Peak oxygen uptake: the most oxygen the body can use during maximal exercise.Peak oxygen uptake: the most oxygen the body can use during maximal exercise.Peak oxygen uptake: the most oxygen the body can use during maximal exercise.

Terms

GOAL
Name of a 2026 Australian cluster randomized trial of comprehensive geriatric assessment in frail older adults with CKD.Name of a 2026 Australian cluster randomized trial of comprehensive geriatric assessment in frail older adults with CKD.Name of a 2026 Australian cluster randomized trial of comprehensive geriatric assessment in frail older adults with CKD.Name of a 2026 Australian cluster randomized trial of comprehensive geriatric assessment in frail older adults with CKD.
FRAILMar
Name of the 2025 Spanish randomized trial of prehabilitation in kidney transplant candidates (Hospital del Mar, Barcelona).Name of the 2025 Spanish randomized trial of prehabilitation in kidney transplant candidates (Hospital del Mar, Barcelona).Name of the 2025 Spanish randomized trial of prehabilitation in kidney transplant candidates (Hospital del Mar, Barcelona).Name of the 2025 Spanish randomized trial of prehabilitation in kidney transplant candidates (Hospital del Mar, Barcelona).
Prehabilitation
Building strength, nutrition, and mental readiness before surgery.Pagpapalakas ng katawan, nutrisyon, at isip bago ang operasyon.Pagpalig-on sa lawas, nutrisyon, ug hunahuna sa dili pa ang operasyon.Pamagpasikan ning katawan, nutrisyun, at isip bayu ning operasyun.
Frailty
Low physical reserve: weak grip, slow walking, exhaustion, low activity, or unintended weight loss.Mababang pisikal na reserba: mahinang hawak, mabagal na lakad, labis na pagod, kaunting galaw, o hindi sinasadyang pagpayat.Ubos nga pisikal nga reserba: huyang nga kupot, hinay nga lakaw, grabe nga kakapoy, gamay nga lihok, o wala tuyoa nga pagniwang.Mababang pisikal a reserba: malunus a kapit, malambang lakad, mapagal a pagal, dikit a galo, o e sasadyang pamagpayat.
Prefrail
Having one or two frailty signs; a stage that can still be reversed.May isa o dalawang palatandaan ng frailty; yugtong maaari pang ibalik.Adunay usa o duha ka timailhan sa frailty; yugto nga mabalik pa.Atin metung o adwang tanda ning frailty; yugtu a malyari pang ibalik.
Sarcopenia
Loss of muscle strength and mass.Pagkawala ng lakas at dami ng kalamnan.Pagkawala sa kusog ug gidaghanon sa kaunoran.Pamakawala ning sikan at dakal ning laman.
Myosteatosis
Fat infiltrating muscle, seen on CT scans; a marker of poor muscle quality.Fat infiltrating muscle, seen on CT scans; a marker of poor muscle quality.Fat infiltrating muscle, seen on CT scans; a marker of poor muscle quality.Fat infiltrating muscle, seen on CT scans; a marker of poor muscle quality.
Catabolic
A state in which the body breaks down more tissue than it builds.Estado kung saan mas maraming tissue ang sinisira ng katawan kaysa binubuo.Kahimtang diin mas daghang tisyu ang gibungkag sa lawas kaysa gitukod.Kalagayan nung nu mas dakal a tissue ing lulungkagan ning katawan kesa bubuan.
Inspiratory muscle training
Breathing against a small spring-loaded valve to strengthen the diaphragm.Paghinga laban sa maliit na valve na may spring para palakasin ang diaphragm.Pagginhawa batok sa gamay nga valve nga adunay spring aron palig-onon ang diaphragm.Pamangisnawa laban king malating valve a maki spring bang pasikanan ing diaphragm.
Resistance training
Exercise that makes muscles work against a load, such as chair stands or weights.Ehersisyong pinagagawa ang kalamnan laban sa bigat, gaya ng pagtayo mula sa upuan o pabigat.Ehersisyo nga pabuhaton ang kaunoran batok sa bug-at, sama sa pagbarog gikan sa lingkoranan o pabug-at.Ehersisyu a pagawan ing laman laban king bayat, antimo ning pamipalto ibat king lukluk o pabigat.
Intradialytic exercise
Exercise done in the chair during hemodialysis, usually pedaling.Ehersisyong ginagawa sa upuan habang naka-hemodialysis, karaniwang pagpe-pedal.Ehersisyo nga gibuhat sa lingkoranan samtang naka-hemodialysis, kasagaran pag-pedal.Ehersisyu a gagawan king lukluk kabang naka-hemodialysis, karaniwan pamedal.
Plant-to-total protein ratio
The share of daily protein that comes from plant foods.Ang bahagi ng protina sa isang araw na galing sa halaman.Ang bahin sa adlaw-adlaw nga protina nga gikan sa tanom.Ing bage ning protina king metung a aldo a ibat king tanaman.
Polypharmacy
Taking many medicines at the same time.Pag-inom ng maraming gamot nang sabay-sabay.Pag-inom og daghang tambal nga dungan.Pamanginum dakal a gamot king sabayan.
Tacrolimus
An anti-rejection medicine whose blood level is changed by some foods, such as pomelo and grapefruit.Gamot laban sa rejection na nababago ang level sa dugo ng ilang pagkain, gaya ng suha at grapefruit.Tambal batok sa rejection nga mausab ang lebel sa dugo sa pipila ka pagkaon, sama sa suha ug grapefruit.Gamot laban king rejection a mababago ing level king daya dareng pilan a pamangan, antimo ning suha ampo grapefruit.
Surrogate endpoint
A measurement (such as grip or muscle size) used in place of outcomes patients feel, such as survival or complications.A measurement (such as grip or muscle size) used in place of outcomes patients feel, such as survival or complications.A measurement (such as grip or muscle size) used in place of outcomes patients feel, such as survival or complications.A measurement (such as grip or muscle size) used in place of outcomes patients feel, such as survival or complications.
ReferencesMga SanggunianMga TinubdanReng Reperensya 29 sources
  1. Lorenz, E. C., Moore, L. W., Yamagami, M., Garibotto, G., Sasangohar, F., & Dhala, A. (2026). The emerging role of prehabilitation in kidney transplant candidates. Journal of Renal Nutrition, 36(3), 335–340. https://doi.org/10.1053/j.jrn.2026.04.001
  2. Pérez-Sáez, M. J., Muñoz-Redondo, E., Morgado-Pérez, A., Delcros-Forestier, L., Bach, A., Faura, A., Redondo, D., Chamoun, B., Burballa, C., Buxeda, A., Crespo, M., Marco, E., & Pascual, J. (2025). Exercise-based prehabilitation for kidney transplant candidates: The FRAILMar randomized controlled trial. American Journal of Kidney Diseases, 86(5), 634–645.e1. https://doi.org/10.1053/j.ajkd.2025.07.003
  3. Pérez-Sáez, M. J., Morgado-Pérez, A., Faura, A., Muñoz-Redondo, E., Gárriz, M., Muns, M. D., Nogués, X., Marco, E., & Pascual, J. (2021). The FRAILMar study protocol: Frailty in patients with advanced chronic kidney disease awaiting kidney transplantation. A randomized clinical trial of multimodal prehabilitation. Frontiers in Medicine, 8, 675049. https://doi.org/10.3389/fmed.2021.675049
  4. Weaver, C., Orandi, B. J., & McAdams-DeMarco, M. (2025). Exercise prehabilitation in kidney transplant candidates: Insights from the FRAILMar trial. American Journal of Kidney Diseases, 86(5), 591–593. https://doi.org/10.1053/j.ajkd.2025.08.007
  5. Doorenbos, C. S. E., Knobbe, T. J., Kremer, D., Brunello, D., Dijkema, D., van Vliet, I. M. Y., Bemelman, F. J., Berger, S. P., Navis, G., Bakker, S. J. L., Corpeleijn, E., & ACTx Collaborators. (2026). Diet, dietary guideline adherence, and clinical determinants of diet in kidney transplant recipients: Results of the Active Care after Transplantation study. Journal of Renal Nutrition, 36(3), 341–352. https://doi.org/10.1053/j.jrn.2025.10.008
  6. Tsuchida, Y., Kabasawa, H., Uno, C., Nishioka, S., Sofue, T., Fujii, N., Saitoh, M., Narita, I., Yamagata, K., Hoshino, J., Doi, E., & Hosojima, M. (2026). Efficacy of combined exercise and nutritional intervention for nondialysis chronic kidney disease: A systematic review. Journal of Renal Nutrition, 36(3), 410–418. https://doi.org/10.1053/j.jrn.2025.10.018
  7. Uno, C., Nishioka, S., Tsuchida, Y., Kabasawa, H., Doi, E., Sofue, T., Fujii, N., Saitoh, M., Narita, I., Yamagata, K., Hoshino, J., & Hosojima, M. (2026). Combination effect of nutrition and exercise intervention in patients with maintenance dialysis: A systematic review and meta-analysis. Clinical Nutrition ESPEN, 74, 103389. https://doi.org/10.1016/j.clnesp.2026.103389
  8. Knobbe, T. J., Kremer, D., Zelle, D. M., Klaassen, G., Dijkema, D., van Vliet, I. M. Y., Leurs, P. B., Bemelman, F. J., Christiaans, M. H. L., Berger, S. P., Navis, G., Bakker, S. J. L., & Corpeleijn, E. (2024). Effect of an exercise intervention or combined exercise and diet intervention on health-related quality of life-physical functioning after kidney transplantation: The Active Care after Transplantation (ACT) multicentre randomised controlled trial. The Lancet Healthy Longevity, 5(9), 100622. https://doi.org/10.1016/j.lanhl.2024.07.005
  9. McAdams-DeMarco, M. A., Law, A., King, E., Orandi, B., Salter, M., Gupta, N., Chow, E., Alachkar, N., Desai, N., Varadhan, R., Walston, J., & Segev, D. L. (2015). Frailty and mortality in kidney transplant recipients. American Journal of Transplantation, 15(1), 149–154. https://doi.org/10.1111/ajt.12992
  10. McAdams-DeMarco, M. A., Ying, H., Van Pilsum Rasmussen, S., Schrack, J., Haugen, C. E., Chu, N. M., González Fernández, M., Desai, N., Walston, J. D., & Segev, D. L. (2019). Prehabilitation prior to kidney transplantation: Results from a pilot study. Clinical Transplantation, 33(1), e13450. https://doi.org/10.1111/ctr.13450
  11. Lorenz, E. C., Bonikowske, A. R., David-Van Meter, A. C., Munson, C. L., Roschen, C. A., Salstrand, R. M., Wolter, A. D., Murthy, B. V., Davis, L. A., Choi, N. G., & Kennedy, C. C. (2024). A multicenter home-based prehabilitation intervention in kidney transplant candidates. Transplantation Direct, 10(12), e1731. https://doi.org/10.1097/TXD.0000000000001731
  12. Bartlett, S. T., Santi, I., Hachaj, G., Wilund, K. R., Tzvetanov, I., Spaggiari, M., Almario, J., Di Cocco, P., Bianco, F., Hajjiri, Z., Gallon, L., Rana, A., Kumar, S., Benedetti, E., & Motl, R. W. (2025). Resistance-based muscle therapy, frailty, and muscle biopsy findings in kidney transplant candidates: A clinical trial. Kidney Medicine, 7(4), 100978. https://doi.org/10.1016/j.xkme.2025.100978
  13. Huang, N.-S., Hong, J., Nalatwad, A., Li, Y., Ghildayal, N., Ali, N. M., Mathur, A., Orandi, B. J., Segev, D. L., & McAdams-DeMarco, M. A. (2025). Physical domains, access to kidney transplantation, and waitlist mortality. Clinical Transplantation, 39(11), e70388. https://doi.org/10.1111/ctr.70388
  14. Karnabi, P., Massicotte-Azarniouch, D., Marshall, S., & Knoll, G. A. (2024). Physical frailty and functional status in kidney transplantation: A systematic review. Canadian Journal of Kidney Health and Disease, 11, 20543581241300777. https://doi.org/10.1177/20543581241300777
  15. Zorgdrager, M., Liu, Y., Hong, J., Ghildayal, N., Swaab, T. D. A., Bakker, S. J. L., Viddeleer, A. R., Orandi, B. J., Shafaat, O., Weiss, C. R., Segev, D., McAdams-DeMarco, M., & Pol, R. A. (2026). Association of myosteatosis and of graft loss after kidney transplantation: An international observational study. Clinical Journal of the American Society of Nephrology, 21(1), 118–129. https://doi.org/10.2215/CJN.0000000862
  16. Pérez-Fernández, M., McAdams-DeMarco, M. A., Alonso-Fuente, A., López-Ongil, S., Tornero-Molina, F., Rodríguez-Puyol, D., & Martínez-Miguel, P. (2026). Survey of Spanish nephrologists' opinion on the applicability of Fried's geriatric frailty criteria in patients with end-stage renal disease. BMC Nephrology, 27(1), 116. https://doi.org/10.1186/s12882-026-04763-x
  17. Kirkman, D. L. (2025). Frailty in kidney transplant candidates: New therapeutic strategies to intervene. Current Opinion in Organ Transplantation, 30(2), 74–80. https://doi.org/10.1097/MOT.0000000000001205
  18. Quint, E. E., Haanstra, A. J., van der Veen, Y., Maring, H., Berger, S. P., Ranchor, A., Bakker, S. J. L., Finnema, E., Pol, R. A., & Annema, C. (2023). PREhabilitation of CAndidates for REnal Transplantation (PreCareTx) study: Protocol for a hybrid type I, mixed method, randomised controlled trial. BMJ Open, 13(7), e072805. https://doi.org/10.1136/bmjopen-2023-072805
  19. Logan, B., Viecelli, A. K., Johnson, D. W., Comans, T., Gordon, E. H., Gray, L. C., Hawley, C. M., Hickey, L. E., Janda, M., Jaure, A., Jose, M. D., Kiriwandeniya, C., Matsuyama, M., Mihala, G., Nguyen, K.-H., Pascoe, E. M., Paul-Brent, P.-A., Pole, J. D., Polkinghorne, K. R., ... Hubbard, R. E. (2026). A cluster randomized controlled trial (GOAL trial) evaluated a comprehensive geriatric assessment for frail older people with chronic kidney disease. Kidney International, 110(4), 1000–1012. https://doi.org/10.1016/j.kint.2026.05.015
  20. Nixon, A. C. (2026). Comprehensive geriatric assessment for older people living with chronic kidney disease and frailty: Time to set a new goal? Kidney International, 110(4), 796–798. https://doi.org/10.1016/j.kint.2026.07.011
  21. Chadban, S. J., Ahn, C., Axelrod, D. A., Foster, B. J., Kasiske, B. L., Kher, V., Kumar, D., Oberbauer, R., Pascual, J., Pilmore, H. L., Rodrigue, J. R., Segev, D. L., Sheerin, N. S., Tinckam, K. J., Wong, G., & Knoll, G. A. (2020). KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation, 104(4S1), S11–S103. https://doi.org/10.1097/TP.0000000000003136
  22. Ikizler, T. A., Burrowes, J. D., Byham-Gray, L. D., Campbell, K. L., Carrero, J.-J., Chan, W., Fouque, D., Friedman, A. N., Ghaddar, S., Goldstein-Fuchs, D. J., Kaysen, G. A., Kopple, J. D., Teta, D., Yee-Moon Wang, A., & Cuppari, L. (2020). KDOQI clinical practice guideline for nutrition in CKD: 2020 update. American Journal of Kidney Diseases, 76(3 Suppl 1), S1–S107. https://doi.org/10.1053/j.ajkd.2020.05.006
  23. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4S), S117–S314. https://doi.org/10.1016/j.kint.2023.10.018
  24. Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., McBurnie, M. A., & Cardiovascular Health Study Collaborative Research Group. (2001). Frailty in older adults: Evidence for a phenotype. The Journals of Gerontology: Series A, Biological Sciences and Medical Sciences, 56(3), M146–M156. https://doi.org/10.1093/gerona/56.3.m146
  25. Egashira, K., Fukuda, E., Onga, T., Yogi, Y., Matsuya, F., Koyabu, N., Ohtani, H., & Sawada, Y. (2003). Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient. Transplantation, 75(7), 1057. https://doi.org/10.1097/01.TP.0000058545.35041.BE
  26. Tolou-Ghamari, Z. (2025). Tacrolimus, cytochrome P450, interactions with food variables in organ transplant recipients: A current and comprehensive review. Current Drug Metabolism, 25(8), 547–553. https://doi.org/10.2174/0113892002328742241210102522
  27. Haugen, C. E., Thomas, A. G., Chu, N. M., Shaffer, A. A., Norman, S. P., Bingaman, A. W., Segev, D. L., & McAdams-DeMarco, M. (2020). Prevalence of frailty among kidney transplant candidates and recipients in the United States: Estimates from a national registry and multicenter cohort study. American Journal of Transplantation, 20(4), 1170–1180. https://doi.org/10.1111/ajt.15709
  28. McIsaac, D. I., Lee, S., Fergusson, D., Gillis, C., Khadaroo, R. G., Meliambro, A., Muscedere, J., Eskander, A., Moloo, H., Nelson, G., Saha, T., Chun, R., Serrano, P. E., Wijeysundera, D. N., & Taljaard, M. (2026). Home-based prehabilitation for older surgical patients with frailty: A randomized clinical trial. JAMA Surgery, 161(2), 113–123. https://doi.org/10.1001/jamasurg.2025.5288
  29. Annema, C., De Smet, S., Castle, E. M., Overloop, Y., Klaase, J. M., Janaudis-Ferreira, T., Mathur, S., Kouidi, E., Perez Saez, M. J., Matthys, C., Dobbels, F., Ferrari, P., Gołębiewska, J., Mrzljak, A., Girman, P., Perch, M., Lopez-Lopez, V., White, C., Koval, D., ... Monbaliu, D. (2023). European Society of Organ Transplantation (ESOT) consensus statement on prehabilitation for solid organ transplantation candidates. Transplant International, 36, 11564. https://doi.org/10.3389/ti.2023.11564
Dr. W Rivero, MD

W Rivero, MD, FPCP, DPSN

Specialist in Internal Medicine, Nephrology, and Clinical Nutrition. Practicing integrative and evidence-based nephrology across Quezon City, Pampanga, and Bulacan.

· Book an Appointment →

QR code — scan to save Dr. Rivero's contact info

Scan and save